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Executive summary
This is the third report of the national clinical 
audit on perinatal mortality in Ireland using 
the NPEC data collection tool and classification 
system. Anonymised data were reported by 
the 20 Irish maternity units on a total of 500 
perinatal deaths occurring in 2013 arising from 
69,146 births of at least 500g birthweight or 
at least 24 weeks gestation. Stillbirths, early 
neonatal and late neonatal deaths accounted for 
301 (60.2%), 162 (32.4%) and 37 (7.4%) of the 
500 deaths, respectively.
The perinatal mortality rate was 6.7 per 
1,000 births in 2013; corrected for congenital 
malformation, the rate was 4.4 per 1,000 births; 
the stillbirth rate was 4.4 per 1,000 births; and, 
the early neonatal death rate was 2.4 per 1,000 
live births.
Applying the more restrictive World Health 
Organization guideline of reporting perinatal 
deaths with a birthweight of at least 500g 
irrespective of gestation, as the Healthcare 
Pricing Office does in reporting national perinatal 
statistics,there were 273 stillbirths (3.9 per 
1,000 births) and 158 early neonatal deaths 
(2.3 per 1,000 live births) in 2013.1
International comparisons are hampered by 
variation in definitions, availability of screening 
programmes for congenital anomalies and 
national legislation on abortion. Nevertheless, the 
Irish stillbirth rate is low in the European context.
After correction for congenital malformation, 
the perinatal mortality rate across the 20 Irish 
maternity units ranged from 1.1 to 8.1 per 1,000 
births. This shows a greater level of variation 
than was observed in 2011 and 2012.
Major congenital anomaly was the primary 
cause of death in almost one in four (n=69, 
22.9%) of the 301 stillbirths that occurred in 
2013. There was a chromosomal disorder in 
almost half of the 69 stillbirths due to congenital 
anomaly (n=33, 47.8%).
A placental condition, most commonly classified 
as maternal vascular malperfusion, was the 
main cause of death of almost one in four 
stillbirths (n=66, 21.9%). One in ten stillbirths 
(n=30, 10.0%) were due to mechanical factors, 
the vast majority of which were due to the 
umbilical cord being around the baby’s neck 
or another entanglement or a true knot in the 
umbilical cord. For approximately one in four 
stillbirths (n=71, 23.6%) the cause of death 
was unexplained. While this is significantly 
lower than the proportion previously reported 
as unexplained using the Wigglesworth 
Classification System, it is marginally higher 
than in the two previous years.
Major congenital anomaly was the primary cause 
of death of more than half (n=92, 56.8%) of the 
162 early neonatal deaths and approximately 
half of late neonatal deaths (n=18, 48.6%). 
Respiratory disorders were the other main cause 
of early (31%) and late (23%) neonatal deaths. 
The vast majority of these deaths were classified 
as due to severe pulmonary immaturity.
In Ireland in 2013, an autopsy was undertaken 
following 48.5% of stillbirths (n=144 of 297, 
unknown for four cases) and 39.6% of early 
neonatal deaths (n=63 of 159, unknown for 
three cases). These rates are higher than in the 
UK as a whole in 2013 (full autopsy for 44.7% of 
stillbirths and 29.6% of early neonatal deaths).2
1 Healthcare Pricing Office. (2014) Perinatal Statistics Report 2013. Dublin: Health Service Executive. 
For 2013, the National Perinatal Reporting System (NPRS) at the Healthcare Pricing Office (HPO), reported 277 stillbirths (4.0 
per 1,000 births) and 159 early neonatal deaths (2.3 per 1,000 live births). The NPRS is a national data system based on 
data collected from Part 3 of the Birth Notification Form (BNF01) which is used to notify local registrars of all live births and 
stillbirths, including planned domiciliary births, occurring in Ireland (see www.hpo.ie). NPEC is currently in consultation with 
the HPO to consolidate any data differences e.g. definitions, in reporting to both systems. 
2 Manktelow BM, Smith LK, Evans TA, Hyman-Taylor P, Kurinczuk JJ, Field DJ, Smith PW, Draper ES, on behalf of the MBRRACE-UK 
collaboration. Perinatal Mortality Surveillance Report UK Perinatal Deaths for births from January to December 2013. Leicester: 
The Infant Mortality and Morbidity Group, Department of Health Sciences, University of Leicester. 2015.
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The value of placental examination in 
determining cause of perinatal death is well 
documented.3 In 2013, placental histology 
examinations were conducted for almost 
all stillbirths (n=292, 97.0%) and for 84.6% 
of early neonatal deaths (n=137). This 
represents an increase in the rate of placental 
histology examination over recent years. 
Following placental histology examination, 
specific placental conditions were diagnosed 
in 60.3% of stillbirths and 47.4% of early 
neonatal deaths.
The age profile of mothers who experienced 
perinatal loss in 2013 differed somewhat 
from that of all mothers who gave birth in 
the country that year. Close to 60% of the 
population who gave birth in 2013 were 
aged 25-34 years whereas mothers who 
experienced perinatal loss were less often in 
this age range (48.2%).
In terms of ethnicity and occupation, 
while the numbers involved were small, 
ethnic minorities and the unemployed 
were overrepresented in the mothers who 
experienced perinatal deaths: this is similar 
to findings in 2012. Monitoring the socio-
economic status of the pregnant population 
in Ireland is challenging as these data are not 
routinely captured in Irish maternity records 
but further efforts must be made if we are to 
better understand how social disadvantage 
impacts on perinatal outcomes.
Smoking status of the mothers at their time 
of booking was recorded for 421 (90.9%) of 
the 463 women. Of these, 75 (17.8%) were 
smokers– similar to the 17.2% prevalence 
reported for 2012. Most were smoking at 
least 10 cigarettes per day (n=41 of 71, 57.7%; 
quantify smoked unknown for four cases). 
Information on smoking in late pregnancy 
was available for 44 of the 75 smokers 
(58.7%); eight (18.2%) stopped smoking 
during pregnancy. There were four cases with 
a documented history of alcohol abuse and 
seven women had a documented history of 
drug abuse.
Body mass index (BMI) was available for 77.8% 
(n=360) of women who experienced perinatal 
loss in 2013, almost identical to the 78.2% rate 
of recording for 2012. The BMI of 46% of those 
mothers in 2013 was in the healthy range 
(18.5-24.9kgm-2) as was the case in 2011 
and 2012. In each of the three years, 53% of 
the mothers who experienced perinatal loss 
were either overweight or obese albeit with 
fluctuation in the distribution within these 
two groups. 
Over two thirds of the mothers who 
experienced perinatal loss in 2013 had at least 
one previous pregnancy (326 of 463, 70.4%). 
In terms of parity, women who experienced 
perinatal loss were similar to the population 
of women who gave birth in 2013. However, as 
in  previous years, they were more likely to be 
Para+ 3 compared to the general population of 
women delivered.
There were 46 perinatal deaths from multiple 
births, making up 9.9% of all perinatal deaths 
in 2013. This is nearly three times the 
proportion of multiples among all births in 
2013 (3.8%).4 Consequently, the perinatal 
mortality rate of 17.6 per 1,000 multiple births 
was nearly three times the national perinatal 
mortality rate.
Twenty-nine mothers (7%) were admitted to 
the high dependency unit (HDU) following the 
delivery. Six mothers (1.3%) were admitted to 
the intensive care unit.
As well as findings from the clinical audit 
itself, the invited commentary contributed to 
this year’s report by Dr Keelin O’Donoghue, 
Consultant Obstetrician and Gynaecologist 
Cork University Maternity Hospital, is focused 
on the impact of stillbirth. Consideration is 
given to the impact on parents and families, 
healthcare professionals and broader society. 
3 Korteweg FJ, Erwich JJ, Timmer A, van der Meer J, Ravise JM, Veeger NJ, Holm JP. Evaluation of 1025 fetal deaths: proposed 
diagnostic workup. Am J Obstet Gynecol 2012 206:53.e1-53.e12
4 Healthcare Pricing Office. (2014) Perinatal Statistics Report 2013. Dublin: Health Service Executive.
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The importance of research, clinical audit, 
confidential enquiry and raising public 
awareness is highlighted.
There were 37 late neonatal deaths in 2013 
reported to the NPEC, a number that is 
consistent with the annual number of late 
neonatal deaths reported by the Central 
Statistics Office in recent years. At the time 
of writing finalised figures for late neonatal 
deaths in 2013 were not yet published by the 
Central Statistics Office (CSO). Currently in 
Ireland, there is no formal system by which 
maternity units are notified of the outcomes 
for infants referred to paediatric units, 
which could result in underreporting of late 
neonatal deaths to the NPEC. We are working 
with colleagues in the relevant hospitals 
(maternity and paediatric) to address this 
issue.
In summary, the findings of this national 
clinical audit of perinatal mortality highlight 
the inherent need for on-going audit in order 
to identify key factors impacting on adverse 
perinatal outcomes. 
Perinatal mortality is a potential pregnancy 
outcome for any woman.  There is a need 
for a public awareness programme around 
perinatal mortality with an understanding that 
its prevention begins prior to the maternity 
period.  Potential parents must be aware of 
modifiable risk factors in order to improve 
their health and lifestyle before pregnancy.
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Recommendations
•	 The	 establishment	 of	 a	 Confidential	 Enquiry	 for	 
 Stillbirth and Neonatal deaths should be considered 
 in order to enhance the lessons which may improve 
 care.  A suitable starting point may be a retrospective 
 in-depth review of a case series of unexpected 
 perinatal deaths associated with intrapartum events. 
 Such a review would impart additional information on 
 quality of care.
•	 Improved	 antenatal	 detection	 of	 fetal	 growth	 
 restriction with timely delivery is a preventative 
 strategy to reduce perinatal mortality. 
 The generation of customized birth weight 
 centile charts for every woman during pregnancy 
 is recommended and concomitantly, staff should 
 be trained to plot symphysial fundal height 
 and scan weight estimates in order to reduce 
 stillbirths in Ireland.  
•	 The	establishment	of	a	national	perinatal	pathology	 
 service, in association with the Faculty of Pathology, 
 would facilitate an agreed approach to classification 
 of autopsy, placental histology and cytogenetics and 
 would provide equal access to review for all perinatal 
 deaths nationally. A positive initial step would be 
 the development of a standardised national reporting 
 proforma for placental histology.
•	 The	 submission	 of	 anonymised	 placental	 histology	 
 reports on perinatal death to the NPEC as part 
 of this audit. This would facilitate standardised 
 interpretation and classification of placental 
 conditions.
•	 Further	 research	 exploring	 factors	 impacting	 on	 
 autopsy rates, particularly in the case of neonatal 
 deaths, is warranted. 
•	 A	structured	notification	system	should	be	developed	 
 to improve inter hospital communication when 
 neonatal or infant deaths occur in a tertiary or 
 paediatric centre.
•	 Collation	of	an	agreed	national	dataset	for	maternity	 
 services in order to facilitate examination of factors 
 influencing adverse obstetric outcomes including 
 perinatal mortality. This may be achieved through 
 the implementation of the Maternal Newborn - Clinical 
 Management System.
 
•	 Robust	 clinical	 audit	 of	 perinatal	 outcomes	 in	 all	 
 maternity units in Ireland is vital for patient care. 
 Such audit requires the protected time of clinical 
 staff. Funding should be provided by the Health 
 Service Executive to ensure that staffing levels 
 allow protected time for clinical audit. 
 
•	 A	 multidisciplinary	 approach,	 including	 perinatal	 
 pathology, is recommended in the audit of perinatal 
 deaths at unit level.
 
•	 All	 maternity	 units	 should	 continue	 to	 collect	 and	 
 submit data on perinatal deaths to inform the 
 maternity services through the NPEC national audit 
 on perinatal mortality. This should include all 
 neonatal deaths regardless of gestational age or 
 weight at birth. In the case of stillbirths, all babies 
 from 24 weeks gestation or with a birthweight of 
 ≥500g should be reported.
Based on the findings of this report, the NPEC Perinatal Mortality Group 
makes the following recommendations. 
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Data recording
In 2013, there were 20 maternity units in 
Ireland. Anonymised data on the perinatal 
deaths that occurred between January 1 and 
December 31 2013 were collected from all 20 
units using a standardised notification form 
(see Appendix D). This detailed notification 
form, implemented nationally in 2011, was 
based on the validated Centre for Maternal 
and Child Enquiries (CMACE) Perinatal Death 
Notification Form5 and has been endorsed by 
the Clinical Advisory Group at the Institute of 
Obstetrics and Gynaecology, the Faculty of 
Paediatrics and the Health Service Executive 
(HSE) National Obstetric Programme Working 
Group. 
Figure 1 illustrates the flow of information 
involved. To ensure accuracy of information, 
missing or incomplete data were sought from 
respective maternity units.
Definitions and terminology
While individual units define perinatal cases 
similarly, there is some variation. To allow for 
comparison across all units the NPEC used 
the following definitions for the current report:
Stillbirth: Baby delivered without signs of life 
from 24 weeks gestation or with a birthweight 
≥500g.6
Early neonatal death: Death of a live born baby 
occurring within 7 completed days of birth.
Late neonatal death: Death of a live born baby 
occurring after the 7th day and within 28 
completed days of birth.
Live birth: Live birth refers to the complete 
expulsion or extraction from its mother of 
a product of conception, irrespective of the 
duration of the pregnancy, which, after such 
separation, breathes or shows any other 
evidence of life - e.g. beating of the heart, 
pulsation of the umbilical cord or definite 
movement of voluntary muscles - whether 
or not the umbilical cord has been cut or the 
placenta is attached. Each product of such a 
birth is considered live born.7  
Methods
Figure 1: Flow of information in the NPEC data collection process.
5 Centre for Maternal and Child Enquiries (CMACE) (2010) Perinatal Mortality 2008: United Kingdom. London: CMACE
6 Stillbirths Registration Act, 1994.
7 World Health Organisation. Available at: http://www.who.int/healthinfo/statistics/indmaternalmortality/en/
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Total births: For the purpose of calculating 
perinatal mortality rates, the denominator 
used was the number of births (live birth 
and stillbirths) from 24 weeks gestation or 
birthweight ≥500g.
Stillbirth rate: Number of stillbirths per 1,000 
births (live births and stillbirths from 24 weeks 
gestation or weighing  ≥500g). In accordance 
with the World Health Organisation reporting 
guidelines, the Irish Healthcare Pricing Office 
perinatal statistics report on stillbirths with a 
birthweight  ≥500g.8 For consistency, we also 
report the stillbirth rate using the criterion of 
birthweight ≥500g.
Neonatal death rate: Number of neonatal 
deaths per 1,000 live births (from 24 weeks 
gestation or weighing ≥500g). The Irish 
Healthcare Pricing Office perinatal statistics 
report on early neonatal deaths with a 
birthweight  ≥500g. For consistency, we 
also report the neonatal death rate using the 
criterion of birthweight ≥500g.
Overall perinatal mortality rate (PMR): Number 
of stillbirths and neonatal deaths per 1,000 
births (live births and stillbirths from 24 
weeks gestation or weighing  ≥500g). Again 
for consistency with the Irish Healthcare 
Pricing Office reporting of perinatal statistics, 
we also report the neonatal death rate using 
the criterion of birthweight  ≥500g.
Corrected PMR: Perinatal mortality rate 
excluding perinatal deaths associated with or 
due to a congenital malformation.
Booking: Some data sought by the NPEC 
Perinatal Death Notification Form relate to the 
time of booking. Booking in this regard relates 
to the mother’s first antenatal visit at the 
maternity unit.
In utero transfer: The NPEC Perinatal Death 
Notification Form records the intended place 
of delivery at the time of the mother’s first 
antenatal visit and the intended place of delivery 
at onset of labour. For cases where the intended 
place of delivery at booking differed from the 
intended place of delivery at onset of labour it 
was presumed that the care of the mother was 
transferred in utero, i.e. the pregnant woman 
was transfered in utero to the care of another 
maternity unit where her baby was delivered. 
From 2016, in utero transfer will be ascertained 
by a specific question on the NPEC Perinatal 
Death Notification Form.
Parity: The number of completed pregnancies, 
whether live birth or stillbirth, of at least 24 
weeks gestation or with a birthweight ≥500g. 
We refer to parity prior to the pregnancy that 
resulted in a perinatal loss in 2013.
Gravida: The number of times the mother has 
been pregnant, irrespective of duration. We 
refer to gravida prior to the pregnancy that 
resulted in a perinatal loss in 2013.
Classification of abnormal placental histology: 
Abnormal placental findings have been 
classified and are presented under the 
following broad categories: maternal vascular 
malperfusion, fetal vascular malperfusion, 
cord pathology, placental maturation defect, 
chorioamnionitis, villitis and other. This 
is in keeping with recommendations in a 
forthcoming publication from an international 
consensus meeting of pathology. It is 
envisaged that this will optimise classification 
of placental conditions causing or contributing 
to perinatal loss.
Classification of death
The NPEC data collection form requests 
contributors to identify maternal, fetal and 
neonatal conditions, using specific categories, 
which caused or were associated with the 
death. The unit contributor is also requested 
to assign the principal cause of death with 
reference to the post mortem and placental 
pathology if performed. Guidance and 
definitions for completing specific categories 
are described in Appendix E. Briefly described; 
categories include both pathophysiological 
entities and clinical conditions present at 
8 Healthcare Pricing Office. (2014) Perinatal Statistics Report 2013. Dublin: Health Service Executive.
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time of death including placental pathology 
and Intra-Uterine Growth Retardation (IUGR). 
Classification of stillbirths was made using 
the NPEC maternal and fetal classification 
system. In the case of neonatal deaths, the 
NPEC neonatal classification system was 
used to attribute the main neonatal cause 
of death and the NPEC maternal and fetal 
classification system was used to identify 
the underlying obstetric condition/sentinel 
event associated with the death. A notable 
difference in the NPEC neonatal classification 
system is that neonatal deaths occurring after 
22 weeks gestation, previously attributed to 
prematurity, would most often be captured 
under the subcategory of ‘severe pulmonary 
immaturity’.
Rate calculations
To assess perinatal mortality, overall and 
unit-specific perinatal mortality rates (PMRs) 
per 1,000 births and corresponding 95% 
confidence intervals based on the normal 
approximation of the Poisson distribution 
were derived. Stillbirth, neonatal and corrected 
PMRs, which exclude deaths associated with 
or due to a congenital malformation, were 
also calculated. Denominator data on the 
number of live births and stillbirths were 
provided directly by individual maternity 
units. Perinatal deaths are included in a 
maternity unit’s rate if the baby was delivered 
in the maternity unit or if the unit was the 
intended place of delivery but the baby was 
born before arrival. Of the reported perinatal 
deaths in 2013, there were six cases that were 
not included in the rate of a maternity unit. 
These were cases where the mother had not 
received antenatal care from a maternity unit 
or a self-employed community midwife but 
presented to a unit after unattended delivery 
in the community.
Funnel plots
Variations in PMRs between maternity units 
could potentially be due to random chance or 
reflect differences in baseline characteristics 
of the childbearing population. For this reason, 
funnel plots were used to assess performance 
outcomes for individual units in comparison 
to the overall average.9 In brief, the plot is a 
scatter diagram of individual maternity unit 
mortality rates against the number of births 
within that unit. The overall mortality rate 
is indicated by the solid straight line and 
the corresponding 95% confidence interval 
is indicated by the curved dashed line. The 
confidence interval is wider for smaller units, 
which are more prone to variable estimates 
and gradually narrows as the unit size 
increases, hence, giving the diagram a ‘funnel’ 
shape. Maternity units with mortality rates 
lying outside the 95% confidence interval are 
statistically significantly different from the 
overall average. In general, one of 20 units 
would be expected to lie outside the 95% 
confidence interval by chance alone.
Birthweight centile
As with previous reports, we have produced 
charts in this year’s report to highlight the 
issue of failure of fetal growth in utero in 
relation to the stillbirths and early neonatal 
deaths that occurred in Ireland in 2013. To 
do so, we used the Gestation Related Optimal 
Weight (GROW) software10 and coefficients 
derived from the multiple regression analysis 
of data on 11,072 births in six maternity units 
in Dublin, Galway, Limerick and Belfast in 
2008-2009.11
The regression analysis determined the 
Term (i.e. 40 weeks) Optimal Weight (TOW) 
in Ireland to be 3,490.7g. The normal range 
(i.e. the range from the 10th centile weight 
to the 90th centile weight) around the TOW 
was then calculated and the recommended 
9 Spiegelhalter D. (2002) Funnel plots for institutional comparison. Quality and Safety in Health Care; 11(4):390-91.
10  Gardosi J, Francis A. Customised Weight Centile Calculator. GROW version 6.6, 2013 Gestation Network, www.gestation.net
11 Unterscheider J, Geary MP, Daly S, McAuliffe FM, Kennelly MM, Dornan J, Morrison JJ, Burke G, Francis A, Gardosi J, Malone FD. 
The customized fetal growth potential: a standard for Ireland. Eur J Obstet Gynecol Reprod Biol 2013; 166(1):14-7
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proportionality growth function was applied 
to the TOW, the 10th centile term weight 
and the 90th centile term weight in order to 
determine the optimal weight and normal 
range at all gestations (21-44 weeks for the 
stillbirths and early neonatal deaths in Ireland 
in 2013). These steps are described in detail 
in the GROW documentation.
Customised birthweight centiles were also 
derived using the GROW software. There was 
a high level of missing data for maternal 
height and weight with one or both unknown 
for 125 (27.0%) mothers. For these cases, 
we used the median height and weight of 
the mothers with complete data. The GROW 
software also provides estimated customised 
birthweight centiles in cases with missing 
data. Ultimately, customised birthweight 




This section of the report provides details of the 
perinatal mortality rate (PMR), maternal and 
infant characteristics and autopsy uptake. In line 
with previous reports, the findings provided in 
this section relate to stillbirths and early neonatal 
deaths only. Separate sections are then provided 
for stillbirths, early neonatal deaths and late 
neonatal deaths describing clinical management 
and the main cause of death based on the NPEC 
Classification System.
Current legislation on stillbirth registration in 
Ireland is based on the criteria of birthweight 
≥500g or gestation at delivery ≥24 weeks. 
Using these criteria, the 20 Irish maternity units 
reported 69,146 births, of which 500 were 
subsequently classified as perinatal deaths. 
Stillbirths, early neonatal and late neonatal 
deaths accounted for 301 (60.2%), 162 (32.4%) 
and 37 (7.4%) of the 500 deaths, respectively.
The reporting guideline of the World Health 
Organization, adopted by the Irish Healthcare 
Pricing Office in their publication of national 
perinatal statistics, recommends the more 
limited criterion of birthweight ≥500g. In 2013, 
the 20 Irish maternity units reported 69,115 
births weighing ≥500g of which 468 were 
subsequently classified as perinatal deaths. 
Stillbirths, early neonatal and late neonatal 
deaths accounted for 273 (58.3%), 158 (33.8%) 
and 37 (7.9%) of the 468 deaths, respectively.
Thus, it can be seen that while broadening the 
inclusion criteria has a negligible impact on the 
total number of births, it increased the number 
of stillbirths and early neonatal deaths by 10.3% 
(from 273 to 301) and 2.5% (from 158 to 162), 
respectively. This is also evident for the rate of 
each perinatal mortality outcome as detailed in 
Table 1.1.
The stillbirth rate associated with the criteria of 
birthweight ≥500g or delivery gestation ≥24 
weeks was 4.4 per 1,000 births and the early 
neonatal death rate was 2.4 per 1,000 live births 
compared respectively to 3.9 and 2.3 per 1,000 
births based on birthweight ≥500g. The overall 
PMR was 6.7 deaths per 1,000 births and when 
corrected for congenital malformation was 
reduced to 4.4 whereas the respective rates 
based on birthweight ≥500g were 6.2 and 4.0 
per 1,000 births.
Table 1.1: Frequency and rate of perinatal mortality outcomes, 2013
 BWT ≥500g or delivery ≥24 weeks BWT ≥500g
 Number Rate (95% CI) Number Rate (95% CI)
Total births 69,146  69,115 
Stillbirths 301 4.4 (3.9-4.9) 273 3.9 (3.5-4.4)
Early neonatal deaths 162 2.4 (2.0-2.7) 158 2.3 (1.9-2.7)
Perinatal deaths 463 6.7 (6.1-7.3) 431 6.2 (5.6-6.8)
Corrected perinatal deaths 301 4.4 (3.9-4.9) 274 4.0 (3.5-4.4)
Note: BWT=Birthweight; Rate per 1,000 births; 95% CI=95% confidence interval; Corrected perinatal deaths exclude deaths 
associated with or due to a congenital malformation.
Perinatal mortality rate
18  PERINATAL MORTALIT Y IN IREL AND ANNUAL REPORT 2013 
The World Health Organization recommends 
making international comparisons of 
stillbirth rates based on the criteria of 
≥1000g birthweight or ≥28 completed weeks 
gestation. Adopting these criteria, Figure 
1.1 illustrates the Irish stillbirth rate in 2013 
compared to the reported stillbirth rate for 23 
European countries as detailed in a systematic 
analysis of worldwide data on stillbirth for 
2007-2009.12 The Irish stillbirth rate was 
corrected by excluding cases associated with 
or due to a congenital malformation. As can 
be seen, Ireland’s stillbirth rate is low in the 
European context.





















Figure 1.1: Corrected stillbirth rate in Ireland in 2013 compared to stillbirth rate in European 
countries, 2007-2009
12 Cousens S, Blencowe H, Stanton C, Chou D, Ahmed S, Steinhardt L, Creanga AA, Tunçalp O, Balsara ZP, Gupta S, Say L, Lawn JE. 
National, regional, and worldwide estimates of stillbirth rates in 2009 with trends since 1995: a systematic analysis. Lancet 
2011; 377: 1319–30.
Note: Corrected stillbirth rate excludes cases associated with or due to a congenital malformation; Rates based on stillbirths 
among births with ≥1000g birthweight or ≥28 completed weeks gestation
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Table 1.2 compares the perinatal mortality 
outcomes for 2013, based on the criteria of 
birthweight ≥500g or gestation at delivery 
≥24 weeks, with those of the previous five 
years. There are some issues relevant to the 
comparability of the data. Data were based 
on 19 maternity units for 2009 and 2010 
but were based on all 20 maternity units for 
other years. Also for 2008-2010, the data 
for stillbirths were based on birthweights 
≥500g whereas for 2011-2013 the data 
for stillbirths were based on birthweights 
≥500g or gestation at delivery ≥24 weeks. As 
mentioned earlier, the broader criteria leads to 
the inclusion of relatively more stillbirths than 
births thereby yielding a higher stillbirth rate. 
However the stillbirth rate in 2011-2013 (4.2-
4.4 per 1,000 births) was lower than in 2008-
2010 (4.6-4.8 per 1,000 births).
Respectively, the stillbirth rate, the rate 
of early neonatal death, the PMR and the 
corrected PMR were 3%, 19%, 8% and 5% higher 
in 2013 than in 2012. None of these changes 
are statistically significant.
Table 1.2: Comparison of perinatal statistics, 2008-2013
 2008 2009 2010 2011 2012 2013
Total births (N) 75,421 70,250 70,182 74,265 71,755 69,146
Total perinatal deaths (N) 512 477 463 456 445 463
Stillbirth rate 4.7 4.8 4.6 4.3 4.2 4.4
Neonatal death rate 2.1 2.0 2.0 1.9 2.0 2.4
Uncorrected PMR (95% CI) 6.8(6.2-7.4) 6.8(6.2-7.4) 6.6(6.0-7.2) 6.1(5.6-6.7) 6.2(5.6-6.8) 6.7(6.1-7.3)
Corrected PMR (95% CI) 4.9(4.4-5.4) 4.8(4.3-5.3) 4.5(4.0-5.0) 4.1(3.6-4.5) 4.1(3.7-4.6) 4.4(3.9-4.9)
Note: 2009-2010 data are based on 19 maternity units whereas others years’ data are based on 20 maternity units; Rates per 1,000 births; PMR= perinatal 
mortality rate; 95% CI=95% confidence interval; Corrected PMR excludes deaths associated with or due to a congenital malformation.
Comparison of perinatal mortality, 2008-2013
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Based on birthweights ≥500g or gestation 
at delivery ≥24 weeks, the uncorrected PMR 
across the 20 Irish maternity units ranged 
from 1.6 to 9.3 per 1,000 births (Table 1.3); 
the corrected PMR ranged from 1.1 to 8.1 per 
1,000 births. Thus, there was approximately a 
sevenfold difference between the lowest and 
highest PMRs. This level of variation is greater 
than was observed in the corrected PMR 
across units in 2011 and 2012.
While there was little change in the corrected 
PMR between 2012 and 2013 at the national 
level, there were of course fluctuations at the 
level of the individual maternity units. There 
was no correlation between the unit-specific 
corrected PMR in 2012 and 2013. Indeed, the 
rate for seven units in 2013 was approximately 
twice or half the rate for the same unit in 
2012, which may be expected when dealing 
with small numbers in some maternity units.
Table 1.3: Perinatal mortality rates across 20 Irish maternity units in 2012 and 2013
Unit  Uncorrected PMR (95% CI) Corrected PMR (95% CI)
  2013 2013 2012
1  9.3 (5.5-13.2) 8.1 (4.5-11.8) 5.2 (2.4-7.9)
2  8.5 (6.5-10.4) 5.1 (3.6-6.6) 5.5 (4.0-7.1)
3  8.1 (6.1-10.1) 5.3 (3.7-6.9) 4.0 (2.6-5.3)
4  7.9 (6.0-9.8) 5.5 (3.9-7.0) 3.8 (2.5-5.1)
5  7.3 (2.9-11.8) 4.7 (1.1-8.2) 5.4 (1.8-8.9)
6  6.8 (3.2-10.5) 4.9 (1.8-8.0) 2.4 (0.3-4.6)
7  6.8 (3.0-10.6) 3.1 (0.6-5.7) 3.1 (0.6-5.7)
8  6.7 (3.8-9.6) 4.1 (1.8-6.4) 3.3 (1.3-5.2)
9  6.5 (4.7-8.2) 3.5 (2.2-4.8) 3.3 (2.0-4.5)
10 6.1 (2.4-9.8) 2.2 (0.0-4.4) 2.7 (0.3-5.0)
11 6.1 (3.8-8.4) 4.3 (2.4-6.3) 4.3 (2.4-6.1)
12 5.5 (3.0-7.9) 4.1 (2.0-6.2) 4.9 (2.6-7.2)
13 5.0 (0.9-9.1) 5.0 (0.9-9.1) 2.6 (0.0-5.5)
14 4.7 (1.4-8.0) 2.9 (0.3-5.5) 7.0 (3.0-11.1)
15 4.1 (1.4-6.8) 2.3 (0.2-4.3) 3.1 (0.8-5.5)
16 4.0 (1.2-6.9) 4.0 (1.2-6.9) 2.4 (0.3-4.6)
17 4.0 (1.2-6.9) 2.0 (0.0-4.0) 3.7 (1.1-6.3)
18 3.2 (0.3-6.1) 1.3 (0.0-3.1) 4.4 (1.1-7.6)
19 2.2 (0.0-4.4) 1.1 (0.0-2.7) 6.2 (2.6-9.8)
20 1.6 (0.0-3.9) 1.6 (0.0-3.9) 3.1 (0.0-6.2)
All 6.7 (6.1-7.3) 4.4 (3.9-4.9) 4.1 (3.7-4.6)
Note: Rates per 1,000 births based on birthweights ≥500g or gestation at delivery ≥24 weeks; PMR=perinatal mortality rate; 
95% CI=95% confidence interval; Corrected PMR excludes deaths associated with or due to a congenital malformation; Six 
cases were not included in the rate of a maternity unit as the mother had not received antenatal care from a maternity unit 
or a self-employed community midwife but presented to a unit after unattended delivery in the community.
Variation by maternity unit
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Figure 1.2: Funnel plot of the corrected perinatal mortality rate for Irish maternity units, 2013
The solid horizontal line in Figure 1.2 represents 
the national corrected PMR in 2013 (4.4 deaths 
per 1,000 births) and the curved dashed lines 
represent the 95% confidence interval around 
the national rate which should include the 
corrected PMR of individual units. Statistically 
one in 20 observations can be expected to be 
outside the 95% confidence range. At 8.1 per 
1,000, the corrected PMR of one unit was above 
the upper limit of the 95% confidence interval 
indicating that it was statistically significantly 
higher than the overall rate in 2013. In recent 
years the rate for this unit was similar to the 
national rate.
In Figure 1.3, the solid horizontal line represents 
the national stillbirth rate of 4.4 per 1,000. In 19 
of the 20 maternity units the stillbirth rate was 
within the limits of the 95% confidence interval. 
At 7.7 per 1,000, the stillbirth rate of one unit, 
the unit that had the outlying corrected PMR, 
was above the upper limit of the 95% confidence 
interval indicating that it was statistically 
significantly higher than the national rate. The 
rate for this unit was in line with the national rate 
in recent years.
Figure 1.3: Funnel plot of the stillbirth rate for Irish maternity units, 2013
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Figure 1.4: Funnel plot of the early neonatal mortality rate for Irish maternity units, 2013
The solid horizontal line in Figure 1.4 represents 
the overall neonatal mortality rate of 2.4 per 
1,000 live births. The neonatal mortality rate from 
one of the country’s large maternity units was 
above the upper limit of the confidence interval 
indicating that it was statistically significantly 
higher than the national rate. However, one third 
of the early neonatal deaths for this unit followed 
in utero transfer from another unit, a higher 
proportion than for any other unit in the country.
In 2011 and 2012 one of the four large maternity 
unit’s had a neonatal mortality rate above the 
national rate. This finding related to a different 
unit in each of the three years. Statistically it 
can be expected for one in 20 observations to 
be outside the 95% confidence range. The profile 
of mothers delivered may differ across Irish 
maternity units and this may explain variation in 
perinatal mortality rates. However, to establish 
this requires more detailed information on all 
mothers delivered at Irish maternity units than 
is currently available.
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In Ireland, women with high risk pregnancies 
may be transferred to the care of tertiary 
maternity units with facilities for specialist 
fetal medicine and high-level neonatal 
intensive care. Of the 463 perinatal deaths in 
2013, there were 51 cases (11.0%) where the 
care of the pregnant woman was transferred 
in utero. Of the 445 perinatal deaths in 2012, 
there were 38 cases (8.5%) where the care of 
the pregnant woman was transferred in utero.
The 51 in utero transfer cases in 2013 resulted 
in 17 stillbirths (33.3%) and 34 early neonatal 
deaths (66.7%). For all but two cases (n=49, 
96.1%) the mother was referred to a tertiary 
maternity unit. Forty-six of the 51 in utero 
transfer cases were transferred to one of the 
country’s four large maternity hospitals. For 
these hospitals in 2013, one in six (n=46, 
17.3%) of their 220 perinatal deaths arose 
from in utero transfer cases. This proportion 
varied across the four hospitals from 7.4% for 
one hospital, 13.3% for another and for two 
hospitals almost one in four of their perinatal 
deaths had been transferred in utero from 
another unit (22.7% and 23.9%). This shows 
the impact on perinatal mortality rates for 




The mothers who experienced perinatal loss 
in 2013 ranged in age from teenage years 
through to late-forties. Their age distribution 
broadly reflected that of the population of 
mothers who gave birth in Ireland (Table 
1.4). Close to 60% of the population who gave 
birth in 2013 were aged 25-34 years whereas 
mothers who experienced perinatal loss were 
less often in this age range (48.2%). The 
age profile of mothers who experienced a 
stillbirth was similar to that of mothers who 
experienced early neonatal death.
Maternal characteristics
 Age group Perinatal deaths Perinatal deaths All births13 Stillbirths Neonatal deaths
  (N=440*) (N=461*)  (N=300) (N=161)
  2011 2013 2013 2013 2013
 <20yrs 14(3.2) 10(2.2) 2.0% 7(2.3) 3(1.9)
 20-24yrs 44(10.0) 53(11.5) 9.3% 37(12.3) 16(9.9)
 25-29yrs 78(17.7) 82(17.8) 20.1% 56(18.7) 26(16.1)
 30-34yrs 141(32.0) 140(30.4) 36.7% 88(29.3) 52(32.3)
 35-39yrs 118(26.8) 136(29.5) 26.0% 85(28.3) 51(31.7)
 >40yrs 45(10.2) 40(8.7) 5.9% 27(9.0) 13(8.1)
Note: Values are shown as n(%) unless otherwise stated. *Maternal age unknown for five cases in 2012 and two cases in 2013.
Table 1.4: Age distribution of mothers experiencing perinatal loss in 2012 and 2013
13 Healthcare Pricing Office. (2014) Perinatal Statistics Report 2013. Dublin: Health Service Executive.
The findings presented below are based on stillbirths and early neonatal deaths born with a 
birthweight ≥500g or gestation at delivery ≥24 weeks.
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Occupation
Lower socio-economic status has been 
shown to be associated with poor pregnancy 
outcomes.14 In the NPEC national clinical 
audit, data on the mother’s and father’s 
occupation at booking was sought. No data 
were recorded for 64 (13.8%) of the 463 
women who experienced perinatal loss down 
from 17.3% unrecorded occupation for 2012. 
Table 1.6 provides a high-level overview of 
the data that were provided on mother’s 
occupation alongside data available for the 
most comparable categories for mothers of 
all births from the Perinatal Statistics Report 
201315 and for the 15-44 year-old female 
population from the National Census 2011.
 
 
An occupation was specified for 64% of the 399 
mothers for whom data were recorded (Table 
1.6), which is lower than the 70% of all mothers 
in 2013 with a specified occupation. A limitation 
of this national audit and data from the 
Perinatal Statistics Report is that occupation 
does not assess employment status. It can 
be seen that unemployed was recorded for 
11% of the mothers experiencing perinatal 
loss compared to 5% of all mothers and 11% of 
the female population aged 15-44 years. The 
proportion specified as engaged in home duties 
was similar for all women who gave birth in 
2013 and for those who experienced perinatal 
loss and was higher than among the general 
population of women aged 15-44 years.
Occupation Perinatal deaths All births16 15-44 year-old
 n(%) (%) female population
Occupation specified 256(64.2) 70.0 55.0%*
Unemployed 44(11.0) 4.7 10.5%
Home duties 86(21.6) 20.4 12.1%
Student 13(3.3) n/a 19.9%
Others not in labour force 0(0.0) n/a 2.5%
Note: Population data from Census 2011 relates to economic status rather than occupation, hence * represents the proportion 
in employment.
Table 1.6: Occupation at booking of mothers experiencing perinatal loss, 2013
Ethnicity
Assessment of risk of perinatal loss 
associated with ethnic group is impeded by 
the absence of national data on ethnicity for 
the pregnant population in Ireland. Three-
quarters of the mothers who experienced 
perinatal loss were of white Irish ethnicity. 
This is close to the proportion of white Irish 
women in the female population aged 15-49 
years enumerated by the National Census 
2011. While the numbers involved were small, 
Irish Traveller, Asian and Black ethnicities 
were overrepresented in the mothers who 
experienced perinatal deaths in 2013 as they 
were in 2012, together accounting for 11% of 
these mothers compared to 5% of the female 
15-49 year-old population.
Ethnicity Perinatal deaths Perinatal deaths 15-49 year-old female 
 2012 2013 population, 2011
White Irish 343(77.1) 348(75.2) 80.4%
Irish Traveller 16(3.6) 12(2.6) 0.7%
Other white background 49(11.0) 53(11.4) 12.5%
Asian/Asian Irish 16(3.6) 18(3.9) 2.4%
Black/Black Irish 12(2.7) 23(5.0) 1.6%
Other/mixed 6(1.3) 2(0.4) 1.0%
Not recorded 3(0.7) 7(1.5) 1.4%
Note: Values are shown as n(%) unless otherwise stated. Population data from the National Census 2011
Table 1.5: Ethnicity of mothers experiencing perinatal loss in 2012 and 2013
14 Centre for Maternal and Child Enquiries (CMACE) (2010) Perinatal Mortality 2008: United Kingdom. London: CMACE
15 Healthcare Pricing Office. (2014) Perinatal Statistics Report 2013. Dublin: Health Service Executive.
16 Healthcare Pricing Office. (2014) Perinatal Statistics Report 2013. Dublin: Health Service Executive.
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Gestation at booking
Gestation at the time of the mother’s first 
antenatal visit to the maternity hospital was 
unrecorded for 48 cases of perinatal death 
in 2013 (10.4%). Of those with data, one in 
five booked into hospital before 12 weeks 
gestation, almost two-thirds attended for 
antenatal care between 12 and 19 weeks 
gestation and 11% attended at 20 weeks 
gestation or later (Table 1.7).
Gestation at Perinatal deaths Perinatal deaths Stillbirths Neonatal deaths
booking 2012 2013 2013 2013
Less than 12 Weeks 104(25.7) 86(20.7) 61(21.6) 25(18.8)
12-19 Weeks 253(62.5) 270(65.1) 185(65.6) 85(63.9)
20 Weeks or Later 43(10.6) 47(11.3) 27(9.6) 20(15.0)
Not Booked 5(1.2) 12(2.9) 9(3.2) 3(2.3)
Table 1.7: Weeks gestation at date of first hospital booking in 2012 and 2013
Fertility treatment
For the first time in 2013, the NPEC Notification 
Form contained a specific question on whether 
the pregnancy resulting in perinatal loss was 
the result of fertility treatment. Information 
was available for 413 of the 463 cases of 
perinatal death. In 29 of these cases (7.0%) 
the pregnancy was reported to be the result 
of fertility treatment (n=14 of 297 stillbirths, 
5.1% and n=15 of 162 early neonatal deaths, 
10.6%). Eleven of these 29 pregnancies were 
associated with multiple births ending in 
perinatal loss of one or more infants.
The method of treatment was specified for 24 
of the 29 pregnancies resulting from fertility 
treatment. In order of frequency, the methods 
were: in vitro fertilisation (n=11), clomid 
(n=7), intracytoplasmic sperm injection (n=2), 
menopur (n=1) and other (n=3).
17 Savitz, D.A.; Kaufman, J.S.; Dole, N.; Siega-Riz, A.M.; Thorp, J.M., Jr; Kaczor, D.T. Poverty, education, race, and pregnancy 
outcome. Ethn. Dis. 2004, 14, 322–329.
Note: Values are shown as n(%) unless otherwise stated.
The NPEC Perinatal Death Notification Form 
records the highest level of education 
completed by the mother but this was not 
provided for the vast majority of the 463 women 
(338, 73.9%). Level of education is not usually 
captured in maternity records but has been 
found to be associated with poor pregnancy 
outcome.17
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Smoking and substance abuse
Smoking status of the mothers at their time of 
booking was recorded for 421 (90.9%) of the 
463 women. Of these, 75 (17.8%) were smokers 
at the time – similar to the 17.2% prevalence 
reported for 2012. Most were smoking at 
least 10 cigarettes per day (n=41 of 71, 57.7%; 
quantity unknown for four cases). Information 
on smoking in late pregnancy was available for 
44 of the 75 smokers (58.7%); eight (18.2%) 
stopped smoking during pregnancy.
 
The prevalence of smoking during pregnancy 
or in the last trimester is not routinely known 
for all Irish pregnancies but rates of 12%, 
15%, 16% and 19% have been reported for 
England, Northern Ireland, Wales and Scotland, 
respectively.21
There were four cases with a documented 
history of alcohol abuse and seven women had 
a documented history of drug abuse.
18 Rasmussen SA, Chu SY, Kim SY, Schmid CH, Lau J. Maternal obesity and risk of neural tube defects: a metaanalysis. Am J 
Obstet Gynecol 2008;198:611-9
19 Chu SY, Kim SY, Lau J, Schmid CH, Dietz PM, Callaghan WM, et al. Maternal obesity and risk of stillbirth: a metaanalysis. Am J 
Obstet Gynecol 2007;197:223-8.
20 Harrington J, Perry IJ, Lutomski J, Morgan K, McGee H, Shelley E, Watson D. (2008) Survey of Lifestyle, Attitudes and 
Nutrition in Ireland: Dietary Habits of the Irish Population. Dublin: The Stationery Office. 
21 EURO-PERISTAT Project with SCPE and EUROCAT. European Perinatal Health Report. The health and care of pregnant women 
and babies in Europe in 2010. May 2013. Available www.europeristat.com
Body mass index
Increased maternal BMI has been associated 
with an increased risk of congenital anomaly 
and stillbirth.18,19 The recording of BMI in 
maternity records is a key recommendation 
of the Obesity and Pregnancy Clinical Practice 
National Guideline. While this may be common 
practice, no national data on the BMI of the 
pregnant population are available.
Body mass index (BMI) was available for 77.8% 
(n=360) of women who experienced perinatal 
loss in 2013, almost identical to the 78.2% rate 
of recording for 2012. The BMI of 46% of those 
mothers in 2013 was in the healthy range 
(18.5-24.9kgm-2) as was the case in 2011 
and 2012. In each of the three years, 53% of 
the mothers who experienced perinatal loss 
were either overweight or obese albeit with 
fluctuation in the distribution into these two 
groups. The pattern of BMI in the mothers who 
experienced perinatal loss remains similar to 
that in the women from the general population 
who participated in the 2007 Survey of 
Lifestyle, Attitudes and Nutrition (SLÁN).20 
Table 1.8: Body mass index of mothers who experienced perinatal loss in 2011-2013
BMI Category (kgm-2) Perinatal deaths Perinatal deaths Perinatal deaths  SLÁN
 2011 2012 2013 2007
Underweight (<18.5) 4(1.3) 2(0.6) 6(1.7) 2%
Healthy (18.5-24.9) 140(45.9) 161(46.3) 164(45.6) 44%
Overweight (25.0-29.9) 83(27.2) 116(33.3) 98(27.2) 31%
Obese (>30.0) 78(25.6) 69(19.8) 92(25.6) 23%
Note: Values are shown as n(%) unless otherwise stated; SLÁN, Survey of Lifestyle, Attitudes and Nutrition
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Table 1.10 specifies gravida/parity for the 460 
women who experienced perinatal loss in 2013 
(gravida/parity was unknown for three women 
with a previous pregnancy). Thirty percent 
(n=137, 29.8%) had never been pregnant before 
(gravida = 0). Of the 323 women who had been 
pregnant (gravida > 0), most (n=181, 56.0%) 
only had pregnancies exceeding 24 weeks or 
500g birthweight (gravida = parity, indicated 
by green shading); one in three (n=105, 32.5%) 
experienced at least one pregnancy exceeding 
24 weeks or 500g birthweight and at least one 
pregnancy less than 24 weeks gestation and under 
500g birthweight (gravida > parity > 0, indicated 
by yellow shading); and, for 11.5% (n=37) their 
previous pregnancies never exceeded 24 weeks 
gestation or 500g birthweight (gravida > parity = 
0, indicated by orange shading).
Table 1.10: Gravida/parity of mothers prior to experiencing perinatal loss in 2013
Note: We refer to gravida and parity prior to the pregnancy followed by perinatal death in 2013. Green represents women with previous pregnancies 
always ≥24 weeks or ≥500g; yellow represents women who had experienced pregnancy ≥24 weeks or ≥500g and pregnancy <24 weeks and 






 0 1 2 3 4 5 6 7 8 13 Total
0 137 0 0 0 0 0 0 0 0 0 137
1 23 93 0 0 0 0 0 0 0 0 116
2 12 26 50 0 0 0 0 0 0 0 88
3 2 12 26 25 0 0 0 0 0 0 65
4 0 2 6 8 8 0 0 0 0 0 24
5 0 1 3 4 1 3 0 0 0 0 12
6 0 0 1 0 1 3 1 0 0 0 6
7 0 0 0 3 0 1 0 0 0 0 4
8 0 0 0 1 0 0 1 1 0 0 3
9 0 0 0 0 0 0 0 1 0 0 1
10 0 0 1 0 0 0 0 0 0 0 1
11 0 0 0 0 0 0 0 0 0 0 0
12 0 0 0 0 0 0 0 1 0 0 1
13 0 0 0 0 0 0 0 0 0 1 1
14 0 0 0 0 0 0 0 0 0 0 0
15 0 0 0 0 0 0 0 0 1 0 1
Total 174 134 87 41 10 7 2 3 1 1 460
Previous pregnancy
Over two thirds of the mothers who experienced 
perinatal loss in 2013 had at least one previous 
pregnancy (326 of 463, 70.4%). 
In terms of parity, women who experienced 
perinatal loss were similar to the population 
of women who gave birth in 2013. However, as 
in previous years, (Table 1.9) they were more 
likely to be Para+ 3 compared to the general 
population of women delivered. 
Parity Perinatal deaths Perinatal deaths Perinatal deaths  All births22
 2011 2012 2013 2013
Nulliparous 205(45.5) 186(41.8) 174(37.6) 38.5%
Para 1 122(27.1) 129(29.0) 137(29.6) 35.1%
Para 2 71(15.7) 72(16.2) 87(18.8) 17.3%
Para 3+ 53(11.7) 58(13.0) 65(14.0) 9.1%
Note: Values are shown as n(%) unless otherwise stated.
Table 1.9: Distribution of parity, 2011-2013
22 Healthcare Pricing Office. (2014) Perinatal Statistics Report 2013. Dublin: Health Service Executive.
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Table 1.11: Previous pregnancy-related problems in mothers who experienced perinatal loss in 2011-2013
 2011 2012 2013 
 n(%) n(%) n(%)
Previous caesarean delivery 55(18.9) 60(19.9) 61(18.7)
Three or more miscarriages 19(6.5) 13(4.3) 14(4.3)
Pre-term birth or mid-trimester loss 11(3.8) 13(4.3) 14(4.3)
Pre-eclampsia 18(6.2) 19(6.3) 13(4.0)
Baby with congenital anomaly 7(2.4) 9(3.0) 10(3.1)
Stillbirth 5(1.7) 11(3.7) 9(2.8)
Neonatal death 7(2.4) 3(1.0) 5(1.5)
Infant requiring intensive care 8(2.7) 6(2.0) 4(1.2)
Post-partum haemorrhage requiring transfusion 5(1.7) 6(2.0) 3(0.9)
Placental abruption 2(0.7) 4(1.3) 1(0.3)
Placenta praevia 1(0.3) 1(0.3) 1(0.3)
Other 68(23.4) 54(17.9) 39(12.0)
Note: Percentage of mothers who had a previous pregnancy
Pre-existing medical conditions
Information about pre-existing medical 
problems was available for 440 of the 463 
mothers who experienced perinatal loss 
(95.0%). One in three of these 440 women 
had a pre-existing medical problem (146, 
33.2%). This is lower than the 40% rate 
in 2012 and the 45% rate in 2011. There 
were no highly prevalent conditions and 
no notable changes in the prevalence of 
specific problems from 2011 to 2013 (Table 
1.12). The Other category included a wide 
range of problems such as asthma, anaemia, 
infertility and urinary tract infection.
 2011 2012 2013
 n(%) n(%) n(%)
Psychiatric disorder 23(5.7) 19(4.5) 25(5.7)
Endocrine disorder 19(4.7) 21(5.0) 17(3.9)
Diabetes 7(1.7) 8(1.9) 13(3.0)
Cardiac disease 8(2.0) 6(1.4) 11(2.5)
Hypertension 12(3.0) 22(5.2) 7(1.6)
Renal disease 7(1.7) 9(2.1) 6(1.4)
Epilepsy 7(1.7) 5(1.2) 4(0.9)
Inflammatory disorder 7(1.7) 7(1.7) 3(0.7)
Haematological disorder 7(1.7) 6(1.4) 3(0.7)
Other 126(31.3) 103(24.3) 92(20.9)
Any pre-existing medical problem 179(44.5) 169(40.0) 146(33.2)
Table 1.12: Pre-existing medical conditions in mothers who experienced perinatal loss in 2011-2013
Of the 326 women who had a previous 
pregnancy, 40% (n=130, 39.9%) were 
reported to have had a previous pregnancy-
related problem (Table 1.11). Almost 
one in five of the 326 mothers had a 
previous caesarean delivery. Three or 
more miscarriages, pre-term birth or mid-
trimester loss and pre-eclampsia were each 




Labour was induced in 60.8% of women who 
experienced a stillbirth (n=183 of 301) and 
13.7% of those who experienced a neonatal 
death (n=22 of 161; unknown for one 
case). A caesarean section was the planned 
mode of delivery for 8.4% of the women 
who experienced a stillbirth (n=25 of 297; 
unknown for four cases) and 25.3% of the 
women who experienced an early neonatal 
death (n=41 of 162).
Approximately 95% of the babies (n=444 of 
463, 95.9%) were delivered under obstetric-
led care which is the predominant model 
of care in Ireland. Six babies (1.3%) were 
delivered under midwifery-led care and 13 
babies (2.8%) were born before arrival at the 
maternity unit (seven stillbirths and six early 
neonatal deaths).
Presentation at delivery, known for 439 of the 
463 babies, was vertex presentation for 73.8% 
(n=324), one in four was breech presentation 
(n=107, 24.4%) and in eight cases the 
presentation was either compound (n=5) or 
face (n=3).
Spontaneous vaginal was the mode of 
delivery for approximately two thirds of 
stillbirths and for almost 40% of the babies 
who died in the early neonatal period (Table 
1.13). Almost half of the deliveries in cases 
of neonatal death involved caesarean section 
(47.5%), usually pre-labour. One in eight cases 
of stillbirth involved caesarean section again 
predominantly pre-labour. Among stillbirths 
delivered by caesarean section, one third of 
the mothers (n=13 of 39, 33.3%) had had a 
previous caesarean delivery. Assisted breech 
deliveries were relatively common in cases of 
stillbirth (16.6%) and neonatal death (11.1%) 
whereas this was a very rare mode of delivery 
for all births in 2013.
Table 1.13: Mode of delivery for mothers who experienced perinatal loss in 2013
Mode of delivery Stillbirths Neonatal deaths  All births23
 (N=301) (N=162) %
Spontaneous vaginal delivery 209(69.4) 63(38.9) 55.2%
Pre-labour caesarean section 29(9.6) 51(31.5) 
29.7%
Caesarean section after onset of labour 10(3.3) 26(16.0) 
Lift out forceps 1(0.3) 2(1.2) 
3.8%
Mid-cavity forceps 1(0.3) 1(0.6) 
Rotational forceps - - 
Assisted breech 50(16.6) 18(11.1) 0.4%
Ventouse 1(0.3) 1(0.6) 10.8%
Note: Values are n(%) unless otherwise stated.
Emergency caesarean section delivery was 
the most common type, accounting for 45.2% 
of the 116 cases of perinatal death delivered 
by caesarean section (n=52, unknown for 
one case), over 20% were categorised as 
urgent (n=26, 22.6%) and one in three were 
elective (n=37, 32.2%). The type of caesarean 
delivery did not differ in this regard between 
cases of stillbirth and early neonatal death.
23 Healthcare Pricing Office. (2014) Perinatal Statistics Report 2013. Dublin: Health Service Executive.
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Level of care for mothers post-delivery
For women who experienced perinatal loss 
in 2013, 6.4% were admitted into a high 
dependency unit (HDU) and 1.3% were 
admitted into an intensive care unit (ICU). 
Similar admission rates were reported for 
2011 and 2012 (Table 1.14). Admission to 
the HDU for the mother was more common in 
cases of early neonatal death than stillbirth 
whereas all six ICU admissions occurred 
following stillbirth. Deliveries by emergency 
caesarean section were associated with the 
highest rates of admission to both the HDU 
(n=13 of 52, 25.0%) and ICU (n=4 of 52, 7.7%).
Infant characteristics
The findings presented below are based on 
stillbirths and early neonatal deaths born with 
a birthweight ≥500g or gestation at delivery 
≥24 weeks.
Sex
There were five perinatal deaths for which the 
sex of the baby was indeterminate (sex was 
unreported for one case of stillbirth). Of the 
457 other perinatal deaths, 56% were male 
(n=255, 55.8%). In the overall population 
of births in 2013, 51.3% were male.24 Male 
babies significantly outnumbered female 
babies among early neonatal deaths but only 
marginally so among stillbirths (Table 1.15).
Multiple births
There was an association between perinatal 
death and multiple pregnancies. There were 
46 perinatal deaths from multiple births, 
making up 9.9% of all perinatal deaths in 2013. 
This is nearly three times the proportion of 
multiples among all births in 2013 (3.8%).25 
Consequently, the perinatal mortality rate 
of 17.6 per 1,000 multiple births was nearly 
three times the national perinatal mortality 
rate for all babies.
The 46 perinatal deaths from multiple 
births comprised 20 stillbirths and 26 early 
neonatal deaths. Most (n=17, 65.4%) of the 
26 early neonatal deaths from multiple 
births were due to respiratory disorders, 
most often severe pulmonary immaturity 
and generally associated with spontaneous 
premature labour. The main causes of the 
20 stillbirths from multiple births were twin-
twin transfusion (n=6, 30.0%) and specific 
placental conditions (n=6, 30.0%) while the 
main cause was unexplained for four cases 
(20.0%).
Chorionicity was reported for 39 of the 46 
perinatal deaths from multiple births. There 
was a small excess of cases that were 
 Perinatal deaths Perinatal deaths Perinatal deaths  Stillbirths Neonatal deaths
 2011 2012 2013 2013 2013
Admitted to HDU 27(5.9) 29(6.5) 29(6.4) 11(3.7) 18(11.2)
Admitted to ICU 8(1.8) 7(1.6) 6(1.3) 6(2.0) 0(0.0)





Table 1.14: Post-delivery outcome for mothers who experienced perinatal loss in 2011-2013
Table 1.15: Sex of baby in stillbirths and neonatal deaths in 2013
24 Healthcare Pricing Office. (2014) Perinatal Statistics Report 2013. Dublin: Health Service Executive. 
25 Healthcare Pricing Office. (2014) Perinatal Statistics Report 2013. Dublin: Health Service Executive.
Note: Values are n(%) unless otherwise stated. Admission data unknown for seven women in 2013.
Note: Sex was not reported for one case of stillbirth.
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Gestation
More than two thirds of perinatal deaths in 
2013 were associated with delivery before 
37 weeks gestation (n=323 of 459, 70.4%; 
gestation at delivery unknown for four cases). 
This was the case for 68.5% of stillbirths 
(n=204 of 298; unknown for three cases) 
and 73.9% of early neonatal deaths (n=119 of 
161; unknown for one case). Extremely pre-
term delivery, i.e. delivery at 22-27 weeks 
gestation, was more often associated with 
cases of early neonatal death than cases of 
stillbirth (Figure 1.5).
Birthweight
The most represented birthweight in cases 
of perinatal death was in the range 500-999 
grams (n=117 of 462, 25.3%; birthweight 
unknown for one case). This was more so for 
early neonatal deaths than stillbirths (Figure 
1.6). For almost three quarters of perinatal 
deaths (n=332, 71.9%; n=209, 69.4% of 
stillbirths; n=123, 76.4% of neonatal deaths) 
the birthweight was less than 2,500 grams.
    
Figure 1.5: Distribution of gestational age at delivery in stillbirths and neonatal deaths in 2013
monochorionic diamniotic (n=20, 51.3%) 
compared to dichorionic diamniotic (n=18, 
46.2%) and one case was monochorionic 
monoamniotic. The observed proportion of 
monochorionic diamniotic twins is higher 
than would be expected based on all twin 
deliveries in Ireland.
There were 27 cases where one twin died, 
eight cases where both twins died and three 
cases where one triplet died indicating a total 
of 38 pregnancies. It was reported that 11 of 
these pregnancies were a result of fertility 
treatment (information unknown for six 
pregnancies).
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26 Gardosi J, Francis A. Customised Weight Centile Calculator. GROW version 6.7.6.5(IE), 2015 Gestation Network, www.
gestation.net
27 Unterscheider J, Geary MP, Daly S, McAuliffe FM, Kennelly MM, Dornan J, Morrison JJ, Burke G, Francis A, Gardosi J, Malone 
FD. The customized fetal growth potential: a standard for Ireland. Eur J Obstet Gynecol Reprod Biol 2013; 166(1):14-7
28 Clausson B, Gardosi J, Francis A, Cnattingius S. Perinatal outcome in SGA births defined by customised versus population–
based birthweight standards. BJOG 2001;108:830–4.
29 Royal College of Obstetrics and Gynaecologists. The investigation and management of the small-for-gestational age fetus. 
RCOG Green Top Guideline 2013 (NO.31). Available at: www.rcog.org.uk/files/rcog-corp/22.3.13GTG31SGA_ExecSum.pdf
Birthweight centile
An increased risk of perinatal death has been 
associated with failure of fetal growth in utero. We 
have produced two charts to highlight this issue 
in relation to the stillbirths and early neonatal 
deaths that occurred in Ireland in 2013. To do so, 
we used the Gestation Related Optimal Weight 
(GROW) software26 and coefficients derived from 
the multiple regression analysis of data on 11,072 
births in six maternity units in Dublin, Galway, 
Limerick and Belfast in 2008-2009. 27
The regression analysis determined the Term (i.e. 
40 weeks) Optimal Weight (TOW) in Ireland to be 
3,490.7g. The normal range (i.e. the range from 
the 10th centile weight to the 90th centile weight) 
around the TOW was then calculated and the 
recommended proportionality growth function was 
applied to the TOW, the 10th centile term weight and 
the 90th centile term weight in order to determine 
the optimal weight and normal range at all 
gestations (21-44 weeks for the stillbirths and early 
neonatal deaths in Ireland in 2013). These steps 
are described in detail in the GROW documentation. 
 
 
The optimal weight and normal range for all 
gestations are plotted with the actual birthweights 
of the stillbirths in Figure 1.7 and with the 
birthweights for cases of early neonatal death in 
Figure 1.8. For the stillbirths, it can be seen that 
a high proportion were below the lower limit of 
the normal range (10th centile). In cases of early 
neonatal death, the birthweight was often below 
the normal range, particularly for births after 33 
weeks gestation. However, low birthweight was 
observed less often than for cases of stillbirth.
Figures 1.7 and 1.8 have the limitation of plotting 
actual birthweights against the optimal weight and 
normal range adjusted only for gestational age. 
There is no adjustment for other factors affecting 
birthweight, namely, maternal height, weight, parity 
and ethnic group and infant sex. The use of centiles 
customised for maternal and infant characteristics 
affecting birthweight identifies small babies at 
higher risk of mortality better than population 
centiles.28 Small-for-gestational-age (SGA) refers to 
birthweights below the 10th centile and severely SGA 
refers to birthweights less than the 3rd centile.29
         
Figure 1.6: Distribution of birthweight in stillbirths and neonatal deaths in 2013
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Customised birthweight centiles were derived 
using the GROW software.30 There was a high 
level of missing data for maternal height and 
weight with one or both unknown for 27.0% of 
the mothers (n=125). For these cases, we used 
the median height and weight of the mothers 
with complete data. The GROW software also 
provides estimated customised birthweight 
centiles in cases with missing data. Ultimately, 
customised birthweight centiles were 
calculated for 459 of the 463 mothers (99.1%).
The distribution of customised birthweight 
centiles at all gestations is illustrated for 
stillbirths in Figure 1.9 and for cases of early 
neonatal death in Figure 1.10. At all gestations, 
there were cases spanning the full range of 
birthweight centiles (i.e. 0-100th) but there 
was a clear overrepresentation of cases below 
the median and far more at or near centile zero 
than would be expected in the population of all 
births.


















































Figure 1.7: Optimal birthweight and normal range compared to actual birthweights of stillbirths, 2013
Figure 1.8: Optimal birthweight and normal range compared to actual birthweights in cases of early 
neonatal death, 2013













































Figure 1.9: Distribution of customised birthweight centiles for stillbirths, 2013
Figure 1.10: Distribution of customised birthweight centiles for early neonatal deaths, 2013
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Centile Stillbirth Neonatal death
 (N=298) (N=161)
 Cause of death: major congenital anomaly Cause of death: major congenital anomaly
 Yes (n=78) No (n=220) Yes (n=68) No (n=72)
Zero 35(50.7%) 53(23.1%) 30(32.6%) 4(5.8%)
< 3rd 41(59.4%) 79(34.5%) 46(50.0%) 11(15.9%)
< 10th 49(71.0%) 109(47.6%) 54(58.7%) 18(26.1%)
10-49th 9(13.0%) 66(28.8%) 21(22.8%) 27(39.1%)
50-89th 1(1.4%) 42(18.3%) 8(8.7%) 16(23.2%)
90th+ 10(14.5%) 12(5.2%) 9(9.8%) 8(11.6%)
Note: Centiles could not be calculated for three stillbirths and one early neonatal death
Table 1.17: Distribution of customised birthweight centiles of perinatal deaths due and not due to major 
congenital anomaly, 2013
Cases of stillbirth and early neonatal death 
were at significantly lower birthweight centiles 
when the cause of death was attributed to 
major congenital anomaly (Table 1.17). Most 
of the 69 stillbirths due to congenital anomaly 
(n=41, 59.4%) were severely SGA (<3rd 
customised birthweight centile) whereas this 
was the case for one third of the stillbirths 
due to other causes (n=79, 34.5%). Similarly, 
half of the 92 early neonatal deaths due to 
congenital anomaly (n=46) were severely 
SGA compared to 16% (n=11) of the 69 early 
neonatal deaths due to other causes.
Table 1.16 details the number and percentage 
of stillbirths and early neonatal deaths within 
specific ranges of customised birthweight 
centiles. Low birthweight was associated with 
both groups but particularly with stillbirths. 
Thirty percent had a birthweight at centile zero 
compared to 21% of early neonatal death cases. 
Forty percent of stillbirths were classified as 
severely SGA and over half were SGA compared to 
35% and 45% of the cases of early neonatal death, 
respectively.
SGA may be more prevalent among stillborn 
babies because they may have died some 
days or weeks before being delivered. We do 
not record whether there was evidence of 
maceration in cases of stillbirth but there was 
support for this hypothesis. The data showed a 
correlation whereby the longer the time between 
confirmation of death and time of delivery, the 
lower the customised birthweight centile of the 
stillborn baby.
Centile Stillbirth n(%) Neonatal death n(%)
 (N=298) (N=160)
Zero 88(29.5) 34(21.1)
< 3rd 120(40.3) 57(35.4)




Note: Centiles could not be calculated for three stillbirths and one early neonatal death; Values are n(%).
Table 1.16: Distribution of customised birthweight centiles, 2013
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Autopsy
Current practice guidelines31 recommend that 
parents should be offered a full post-mortem 
examination of the stillborn infant to help 
explain the cause of death. Data on autopsy 
uptake was reported for 456 of the 463 perinatal 
deaths of which 45.4% (n=207) underwent an 
autopsy. This rate of autopsy uptake is identical 
to the 45.2% rate in 2012 and higher than in 2011 
when 40.7% of perinatal deaths had an autopsy 
performed. The trend in the perinatal autopsy 
rate is illustrated in Figure 1.11. A decline in the 
rate of autopsy was observed in 2008-2011. 
The rate is always higher for stillbirths than in 
cases of early neonatal death albeit by a smaller 
margin in recent years.
In Ireland in 2013, an autopsy was undertaken 
following 48.5% of stillbirths (n=144 of 297, 
unknown for four cases) and 39.6% of early 
neonatal deaths (n=63 of 159, unknown for 
three cases). These rates are higher than in the 
UK as a whole in 2013 (full autopsy for 44.7% of 
stillbirths and 29.6% of early neonatal deaths)32 
whereas the autopsy rate in Northern Ireland in 
2013 was higher for stillbirths (60%) and similar 
for early neonatal deaths (41%).33
31 Clinical Practice Guideline No 4 (2011). Investigation and management of late fetal intrauterine death and stillbirth: Institute 
of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical Programmes, 
Health Service Executive.
32 Manktelow BM, Smith LK, Evans TA, Hyman-Taylor P, Kurinczuk JJ, Field DJ, Smith PW, Draper ES, on behalf of the MBRRACE-UK 
collaboration. Perinatal Mortality Surveillance Report UK Perinatal Deaths for births from January to December 2013. Leicester: The 
Infant Mortality and Morbidity Group, Department of Health Sciences, University of Leicester. 2015.
33 Northern Ireland Maternal and Child Health. (2015) Perinatal mortality: Northern Ireland 2013. Belfast: Northern Ireland Public 
Health Agency.
Investigations to determine the cause of death
The NPEC Perinatal Death Notification Form 
contains a specific question on whether a 
diagnosis of IUGR was made in perinatal deaths 
and the timing of diagnosis if applicable. A 
diagnosis of IUGR was reported for 76 (16.6%) 
of the 463 perinatal deaths (unknown for four 
cases) - 17.8% of stillbirths (n=53) and 14.2% of 
early neonatal deaths (n=23). In most diagnosed 
cases, IUGR was suspected antenatally (Table 
1.18). Approximately 80% of the cases with a 
diagnosis of IUGR (n=62 of 76, 81.6%) were 
severely SGA (<3rd customised birthweight 
centile). Major congenital anomaly was the main 
cause of death in almost half of the cases with 
a diagnosis of IUGR (n=36, 47.4%), placental 
conditions were the main or associated cause of 
death in one in four cases (n=17, 22.4%) and IUGR 
was the main or associated cause of death for five 
cases (6.5%).
Among the 421 mothers whose smoking status 
was known at the time of their hospital booking, 
there was little difference in the prevalence 
of diagnosed IUGR in the infants of smokers 
(n=10 of 75, 13.3%) and non-smokers (n=62 of 
346, 17.9%). A diagnosis of IUGR was relatively 
common among mothers with a pregnancy-
related hypertensive disorder (n=11 of 27, 
40.7% versus n=65 of 432 mothers without 
pregnancy-related hypertension, 15.0%).
 Stillbirth n(%) Neonatal death n(%)
 (N=53) (N=23)
Suspected antenatally 34(64.2) 21(91.3)
Observed at delivery 36(67.9) 14(60.9)
Observed at post-mortem 17(32.1) 1(4.3)
Note: Categories are not mutually exclusive and may add up to more than 100%
Table 1.18: Diagnosis of intra-uterine growth restriction, 2013
Diagnosis of intra-uterine growth restriction (IUGR)
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Figure 1.13 details the autopsy-related steps 
taken following 456 of the 463 perinatal deaths 
in 2013. Thirty-one of the deaths (6.8%) became 
coroner cases. These cases underwent autopsy 
and at the time data were reported to the NPEC, 
the maternity unit had received the autopsy 
report from the coroner’s office in 25 of the 
31 cases (80.6%). There were 176 autopsies 
undertaken following the 425 deaths that were 
not coroner cases, an autopsy rate of 41.4% 
(129, 43.4% for stillbirths and 47, 29.6% for early 
neonatal deaths).
There was significant variation in the rate 
of autopsy across the 20 maternity units in 
2013 as illustrated in Figure 1.12. Most of this 
variation was observed across the smaller 
maternity units as the autopsy rate for the 
four large maternity units was 47.0-61.1%. To 
some extent this is a consequence of the small 
numbers of perinatal deaths involved but it may 
also reflect variation in access to dedicated 
perinatal pathology services for smaller units 
– a common communication to the NPEC 
from smaller units. The autopsy rate in each of 
the four large maternity units was above the 
national rate.
Figure 1.12: Autopsy uptake in the 20 Irish maternity units in 2013
Figure 1.11: Autopsy uptake rate, 2008-2013
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The decision not to offer to undertake an 
autopsy may be influenced by the clinical 
scenario and the antenatal diagnosis. There 
was evidence to support this in relation to 
major congenital anomaly. The proportion of 
cases not offered an autopsy was higher if the 
perinatal death was due to a major congenital 
anomaly than if it the death was due to 
another cause (Table 1.19).
Autopsy Stillbirth (N=296 of 301) Neonatal death (N=159 of 162)
 Cause of death: major congenital anomaly Cause of death: major congenital anomaly
 Yes (n=69) No (n=227) Yes (n=91) No (n=68)
Performed 25(36.2%) 119(52.4%) 35(38.5%) 28(41.2%)
Offered 36(52.2%) 101(44.5%) 37(40.7%) 34(50%)
Not offered 8(11.6%) 7(3.1%) 19(20.9%) 6(8.8%)
Note: Data on whether autopsy was performed and/or offered was incomplete for five cases of stillbirth and three cases of early neonatal death.
Table 1.19: Uptake and offer of autopsy of perinatal deaths due and not due to major congenital anomaly, 2013
 
 
         
 

































Figure 1.13: Flowchart describing autopsy-related steps taken after 463 perinatal deaths in 2013
Note: Autopsy unknown for four cases of stillbirth and three cases of early neonatal death. Autopsy offer unknown for one 
case of stillbirth.
There were 249 perinatal deaths that did not 
receive an autopsy. For the majority of these 
cases an autopsy was offered and presumably 
declined by parents (n=208, 83.9%, unknown 
for one case). This is an increase in the rate 
of autopsy offer from 78.0% for 2012. Such an 
offer was made more often in cases of stillbirth 
(137 of 152, 90.1%, unknown for one case) than 
for early neonatal deaths (71 of 96, 74.0%). 
Consequently, in 2013 there were 40 perinatal 
deaths for which an autopsy was not offered, 
constituting 8.6% of all 463 perinatal deaths. 
This is a smaller proportion than in 2012 when 
52 (11.7%) of the 445 perinatal deaths were not 
offered an autopsy.
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Specific placental conditions were generally 
more prevalent among stillbirths than 
among cases of early neonatal death with 
the exception of chorioamnionitis which was 
reported in approximately one in six early 
neonatal deaths and one in eight stillbirths 
(Table 1.20). In the case of stillbirths, 
conditions within the maternal vascular 
malperfusion category were most commonly 
reported (25.0%).
The prevalence rates reported for some specific 
placental conditions in Table 1.20 are lower 
than those reported in previous studies.37,38 
Whether this reflects varying degrees of 
detection, reporting or interpretation of placental 
histology reports warrants further investigation. 
Submission of anonymised placental histology 
reports to the NPEC as part of this audit would 
facilitate standardised interpretation and 
classification of placental conditions at national 
level.
Placental examination
The value of placental examination in 
determining cause of perinatal death is well 
documented.34 In 2013, placental histology 
examinations were conducted for almost all 
stillbirths (n=292, 97.0%) and for 84.6% of early 
neonatal deaths (n=137). Thus, the rate of 
placental histology examination has increased 
for stillbirths from 93% in 2011 to 97% in 2013 
and for early neonatal deaths from 69% in 2011 
to 85% in 2013. Very similar levels of placental 
histology, of 94% for stillbirths and 86% for early 
neonatal deaths, were reported for Northern 
Ireland in 201335 compared to 87.2% of stillbirths 
in the UK as a whole.36
34 Korteweg FJ, Erwich JJ, Timmer A, van der Meer J, Ravise JM, Veeger NJ, Holm JP. Evaluation of 1025 fetal deaths: proposed 
diagnostic workup. Am J Obstet Gynecol 2012 206:53.e1-53.e12
35 Northern Ireland Maternal and Child Health. (2015) Perinatal mortality: Northern Ireland 2013. Belfast: Northern Ireland Public 
Health Agency.
36 Manktelow BM, Smith LK, Evans TA, Hyman-Taylor P, Kurinczuk JJ, Field DJ, Smith PW, Draper ES, on behalf of the MBRRACE-UK 
collaboration. Perinatal Mortality Surveillance Report UK Perinatal Deaths for births from January to December 2013. Leicester: The 
Infant Mortality and Morbidity Group, Department of Health Sciences, University of Leicester. 2015.
37 Beebe LA, Cowan LD, Altshuler G. The epidemiology of placental features: Associations with gestational age and neonatal 
outcome. Obstetrics & Gynecology. 87(5):771-778, 1996.
38 Mooney EE. Implantation and placenta; and Mooney EE, Doyle EM. Non-neoplastic maternal gestational diseases (2014). In: 
Mutter GL, Prat J, eds. Pathology of the Female Reproductive Tract. 3rd edition. London: Churchill Livingstone. ISBN 9780702044977
Specific placental conditions
Abnormal placental findings have been classified 
and are presented under the following broad 
categories: maternal vascular malperfusion, fetal 
vascular malperfusion, cord pathology, placental 
maturation defect, chorioamnionitis, villitis and 
other. This is in keeping with recommendations 
in a forthcoming publication from an international 
consensus meeting of pathology.
 
Of the 292 stillbirths and 137 early neonatal 
deaths for which placental examinations were 
conducted, specific placental conditions in 
at least one of the above categories were 
reported in 176 (60.3%) of stillbirths and 65 
(47.4%) of early neonatal deaths.
 Stillbirth n(%) Neonatal death n(%)
 (N=292) (N=137)
Maternal vascular malperfusion 73(25.0) 25(18.2)
Fetal vascular malperfusion 38(13.0) 9(6.6)
Cord pathology 20(6.8) 4(2.9)
Placental maturation defect* 22(7.5) 6(4.4)
Chorioamnionitis, placenta 37(12.7) 24(17.5)
Villitis 10(3.4) 4(2.9)
Other 34(11.6) 11(8.0)
Any placental condition 176(60.3) 65(47.4)
*Placental maturation defect includes distal villous immaturity and delayed villous maturation.
Table 1.20: Placental histology findings for stillbirths and early neonatal deaths, 2013
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Examination Perinatal Deaths Perinatal Deaths  Stillbirth n(%) Neonatal death n(%)
 2012 2013 2013 2013
External 170(38.2) 247(53.3) 166(55.1) 81(50.0)
X-Ray 63(14.2) 118(25.5) 82(27.2) 36(22.2)
CT scan 2(0.4) 7(1.5) 0(0) 7(4.3)
MRI 4(0.9) 0(0) 0(0) 0(0)
Table 1.21: Other examinations performed in investigating perinatal deaths in 2012 and 2013
Other examinations performed
External examination was made for 
approximately half of the 463 perinatal deaths 
in 2013 compared to 38.2% in 2012 (Table 1.21). 
X-Ray was also reported to have been performed 
more often following perinatal death in 2013 
(25.5%) than in 2012 (14.2%). Computerised 
tomography scans and magnetic resonance 
imaging tests were rarely undertaken. 
External examination and X-ray were carried 
out marginally more often following cases on 
stillbirth in 2013 than for cases of early neonatal 
death.
Cytogenetic analysis is an important 
investigation in the diagnosis of chromosomal 
abnormalities. Some abnormalities are 
potentially recurrent and can be tested for 
in future pregnancies.39 In the event of a 
chromosomal disorder, a specific question 
on the NPEC Perinatal Death Notification form 
asks how the diagnosis was made. A major 
congenital chromosomal disorder was the 
main cause in 58 perinatal deaths in 2013 
(33 stillbirths and 25 early neonatal deaths). 
For two thirds of these cases (n=38, 65.5%), 
the diagnosis was made by cytogenetic 
analysis (n=23 stillbirths, 69.7%; n=15 
neonatal deaths, 60.0%). In 2012, there were 
55 perinatal deaths due to a major congenital 
chromosomal disorder and for three quarters 
of those cases the diagnosis was made by 
cytogenetic analysis (n=41, 74.5%).
Cytogenetic investigation in chromosomal disorders
Note: CT=Computerised tomography, MRI=magnetic resonance imaging
39 Clinical Practice Guideline No 4 (2011). Investigation and management of late fetal intrauterine death and stillbirth: Institute of 
Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical Programmes, Health 
Service Executive.
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In the developed world, one in 200 infants 
is stillborn. This is a devastating outcome of 
pregnancy for parents and for the healthcare 
professionals who look after them. Stillbirth is 
still 10 times more common than sudden infant 
death syndrome and accounts for 70% of all 
perinatal deaths. This latest Perinatal Mortality 
Annual Report from NPEC describes 301 infants 
who were stillborn in 2013.
Many stillbirths do remain unexplained, but 
an unexplained death may in reality be an un-
investigated one. Stillbirths deserve the same 
systematic evaluation as adult deaths, yet the 
study of specific causes of stillbirth has been 
historically hindered by the absence of uniform 
protocols of investigation, lack of agreement on 
definitive classification systems, as well as the 
extent of post-mortem assessment performed. 
In general, the most common causes of stillbirth 
are investigated, as well as those conditions 
that might predispose couples to recurrent 
stillbirth.  Understanding reasons helps parents 
recover, but may also identify recurrence risks 
and even identifying a sporadic cause has merit 
as it can bring closure and provide reassurance. 
An important national advancement has been 
NPEC’s development and implementation in 
2011 of a comprehensive data collection tool 
and classification system for perinatal deaths.
Falling post-mortem rates, related to public 
concerns regarding perinatal autopsy, has 
prompted a search for non-invasive alternatives, 
including post-mortem imaging, and for 
predictive markers of placental dysfunction and 
incipient fetal growth restriction. Despite this, 
the conventional post-mortem examination 
or autopsy remains the gold standard for 
determining the cause of death. Clinicians 
should continue to advocate for this rather 
than inferring a cause and the important role of 
specialist perinatal pathology within maternity 
services needs greater focus.  Many of the 
broad categories of cause of death, including 
unexplained stillbirth, are thought to be related 
to placental function, and while placental 
abnormalities are estimated to occur in over 50% 
of stillbirths, they are still poorly understood and 
sometimes variously reported. Internationally, 
several risk factors have now been associated 
with stillbirth, including advanced maternal 
age, high body mass index, maternal ethnicity, 
fetal growth restriction but understanding of 
the epidemiology remains limited. Numerous 
social, behavioural and lifestyle risk factors 
are reported to be associated with stillbirth, 
but these links are complex, and psychosocial 
and biological factors may interact together to 
increase the risk.
The death of an infant is one of the most 
stressful life events that an adult experiences. 
There is significant psychological morbidity 
associated with prenatal loss at any gestation 
and effects on physical and emotional wellbeing 
may be long-lasting. Provision of an empathetic 
environment with psychological support at the 
time of loss is now an accepted part of care, 
albeit without much evidence yet of improved 
health outcomes. Only a few studies have 
addressed the lived experience of stillbirth 
and there is still relatively little qualitative 
research showing how bereaved parents make 
sense of their loss. In addition to the impact on 
parents and their families, stillbirth has also 
been demonstrated to have a considerable 
impact on healthcare professionals. Studies 
reveal a consistent account of personal and 
professional burden following stillbirth.  Given 
the extensive impact of stillbirth on all involved, 
it is imperative to understand the underlying 
causes. Further, identification of mothers at 
risk for pregnancy loss is a necessary step to 
effective intervention and prevention, and the 
intensity of prenatal care can then be matched 
to each woman’s risk profile.
2. Invited commentary: The impact of stillbirth
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Impact on parents and families
The recognition of stillbirth as a significant 
bereavement is relatively new, but the 
death of an infant is now acknowledged as a 
hugely stressful life event. Perinatal grief is a 
distinctive grief with lasting and lifelong impact 
for parents, who often have complex emotional 
and psychological needs following stillbirth.
Many short and long-term negative outcomes 
for parents have been reported in the aftermath 
of stillbirth, including anxiety, depressive 
symptoms, post-traumatic stress, suicidal 
ideation, guilt, social phobia and remorse. 
Studies have demonstrated that the impact 
of stillbirth contributes significantly to 
relationship strain and breakdown. Factors 
which have been suggested to increase the risk 
of adverse psychological outcomes for parents 
after stillbirth include: inadequate social 
support, traumatic circumstances surrounding 
the death, difficulties in coping with a crisis in 
the past, problematic relationships and the 
presence of other life crises. Of concern is the 
extensive literature regarding the ongoing 
morbidity and mortality that exists for families 
who have experienced infant bereavement, 
including significantly higher levels of anxiety 
and depression in pregnant mothers who had 
previously had a perinatal loss with a negative 
impact on attachment to the subsequent child, 
as well as evidence of increased mortality 
in bereaved parents. Stillbirth has also been 
shown to have a negative impact on siblings, 
grandparents, and other family members.
Bereavement care following stillbirth has 
developed over the last twenty years to reflect 
the increasing understanding of grief. Traditional 
models encouraged a focus on cutting ties with 
the loved one and moving on, whereas modern 
models recognise the value of continuing bonds 
and creating meaning. Stillbirth bereavement 
care now aims to support these grieving tasks 
by facilitating the parents’ expression of grief, 
through ensuring a sensitive non-traumatising 
experience during which they spend time as 
parents with their baby, supporting them in 
creating memories and helping them with 
understanding through investigation.  
The provision of support for parents following 
stillbirth is therefore a key part of overall care 
from the maternity services. This support 
should be initiated from the time of diagnosis 
and extend through the care provided in 
hospital and then following discharge for as 
long as is necessary. Dedicated bereavement 
teams contribute much to the support offered 
to parents, where trained professionals can 
provide specialised and appropriate person-
centred care and follow-up investigations. There 
is however continuing inconsistency in the 
availability of bereavement support across the 
Irish maternity services in 2015, and a heavy 
reliance on the voluntary charitable sector 
to meet the needs of bereaved parents and 
families.
Research has suggested that the role of 
practitioners in the handling of death and 
their interaction with the bereaved from 
the moment of breaking the news of death 
influences the intensity of grief and has the 
potential to positively impact on the grief 
experience of bereaved parents. However, poor 
communication can add to parental distress 
and increase dissatisfaction with care. There 
is, thankfully, increasing recognition of the 
need to offer guidance and training to health-
care professionals involved in communicating 
bad news.  Creation of an empathetic, caring 
environment, and strategies to enable the 
family to accept the reality of stillbirth, are now 
an accepted part of standard care and social 
support. Further, provision of interventions 
such as psychological support or counselling, or 
both, has been suggested to improve outcomes 
for families after a perinatal death, although 
evidence for this is still limited.
Surveys of bereaved parents highlight the 
critical importance of the quality of parents’ 
interactions with staff.  While the specialised 
role of bereavement midwives in particular, 
and other members of the bereavement 
team is always acknowledged, it is clear that 
parents expect the importance of kindness 
and sensitivity to extend to all hospital staff 
including clerical, security, catering, medical, 
chaplaincy and midwifery.  The use of an alert 
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or ‘bereavement’ sticker on the cover of the 
hand held patient file, as used in several UK 
and Irish hospitals, has the potential to remind 
staff to be sensitive, as does the display of a 
similar symbol in clinical areas.  A study on 
bereaved parents’ experience of stillbirth in 
UK hospitals agreed that, “positive memories 
and outcomes depend as much on genuinely 
caring staff attitudes and behaviours as on 
high-quality clinical procedures”. In this way it 
can be seen that empathic care and sensitive 
communication from the bereavement team 
alone is not sufficient. The entire hospital must 
adopt a considerate and supportive approach 
toward parents and families bereaved by 
stillbirth. The conclusion of Soo Downe’s 2013 
paper on bereaved parents experience of 
stillbirth is a worthwhile one to remember: “all 
staff who encounter parents in this situation 
need to see each meeting as their one chance 
to get it right.”
Impact on staff
The lived experiences of bereaved parents have 
contributed much to the published literature on 
stillbirth. However, it is increasingly recognised 
that stillbirth has a considerable impact on 
the personal and professional wellbeing of 
healthcare professionals.  The impact of this 
emotional burden in the wider healthcare 
field is now being openly documented. In a 
questionnaire study of US obstetricians in 
2008 seventy-five percent of respondents 
acknowledged that caring for women following 
stillbirth took a large emotional toll on the 
obstetrician. A recent Irish study confirmed 
that the emotional burden associated with 
stillbirth is considerable and revealed the 
complexity for medical consultants within the 
multi-disciplinary team.  Despite the impact 
of stillbirth, no consultant had received formal 
training in perinatal bereavement care. This 
study highlighted both a gap in training and 
the implications of stillbirth on obstetricians 
professionally and personally, recommending 
the provision of support, ongoing education and 
the need for self-care.
In a meta-analysis of studies (n=20) published 
between 2000-2015, conducted for the 
upcoming 2015 Lancet stillbirth series, all of the 
studies reviewed reported substantial personal 
and professional impacts on staff following 
stillbirth. Four major qualitative themes 
emerged from the review of these papers: 
psychological impact, professional impact, 
need for support, and positive effects for staff. 
Psychological impact was most frequently 
reported with somatic effects such as trauma 
symptomatology, diminished emotional 
availability, stress, and affective states such as 
grief, guilt, anger, self-blame, self-doubt, anxiety 
and sadness. The professional impact of stillbirth 
was characterised by fear of litigation or loss of 
livelihood as well as fear of disciplinary action. 
The majority of studies highlighted the need for 
further education and professional support for 
staff in psychosocial care and communication 
skills. Lack of institutional and structured peer 
support was also highlighted, and many studies 
found that peer support, although valuable, was 
too informal.  Interestingly, staff who felt they 
had received adequate training in stillbirth care 
reported less guilt and less fear of litigation. 
Only six studies noted the positive outcomes 
reported by staff such as a sense of ‘privilege’, 
‘personal growth’ and the development of a 
‘special bond’ with parents. In four studies, staff 
reported more confidence with fewer negative 
effects, where they had more direct clinical 
experience of stillbirth.
The Irish Medical Council’s 2014 report “Your 
training counts” states that there is ample 
evidence to show that “good health and 
wellbeing contribute to good professional 
practice”.  It is acknowledged therein that 
healthcare professionals must provide safe 
effective and compassionate care for patients 
and families at times of great distress, in a 
demanding healthcare context, while trying to 
maintain professional competence. However, 
historically, healthcare professionals, and 
doctors in particular, have been slow to 
recognize the profound effect adverse medical 
outcomes, such as the death of a patient, can 
have on their mental and physical health. 
Doctors have higher rates of mental health 
disorders, including depression, anxiety, 
substance misuse, and “burn out” than other 
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occupational groups yet are reluctant to access 
services that might help.
There is now an increasing body of research 
looking at burnout and compassion fatigue in 
healthcare, although for reasons that are unclear 
very little of this to date has focused specifically 
on the maternity services. Compassion fatigue, 
defined in the literature as the reduced capacity 
for empathy toward patients resulting from 
repeated exposure to their trauma, has been 
linked with maladaptive coping mechanisms 
to stress, chronic exhaustion, absence of 
appropriate debriefing after adverse events and 
lack of training in dealing with death. Burnout, a 
concern in fields dealing with trauma and acute 
stress, also develops in response to intense 
interpersonal situations with high emotional 
and cognitive demands. It has been linked to 
longer working hours and is experienced more 
often by those who work in specialties with 
proportionally higher direct patient contact.
Over the past decade, system changes in 
healthcare have necessarily focused on 
disclosure, reporting, and the patient safety 
culture. However, little attention has been paid 
to creating systems that help the healthcare 
providers, who are involved as the ‘second 
victims’ after an adverse event such as stillbirth 
represents. The literature highlights the 
importance of staff education and professional 
support as gaps in existing service provision 
and as areas that require increased attention 
in healthcare systems. Further research on 
support interventions for staff and the effect 
of this staff support on patient care outcomes 
are needed. Finally, as colleagues in palliative 
care medicine have written:  “the idea of ‘self-
care’ may seem a selfish irrelevance and an 
unjustifiable luxury. In fact, self-care is an 
essential part of the therapeutic mandate.”
Impact on society
The impact of stillbirth on society ranges 
from the obvious loss of a valued human life 
to the effect of this loss directly on families, 
healthcare systems, welfare systems and the 
workplace.  There is a paucity of information in 
the published literature to quantify the exact 
economic cost of stillbirth to society, but these 
costs can be loosely described as direct and 
indirect.  Direct costs associated with stillbirth 
include those related to its management and 
the associated medical investigations, costs 
of funerals and burial arrangements, as well 
as the increased costs of care for subsequent 
pregnancies following stillbirth.  Indirect costs 
are more difficult to quantify and include the 
longer-term costs to society following the 
grief and psychological symptoms that occur 
as part of the impact of stillbirth on parents. 
Other indirect costs include lack of productivity 
through employment absence and reduction 
in working hours. Acknowledgement of the 
personal and professional cost of stillbirth on 
staff raises important issues of staff wellbeing 
and governance, which in turn directly affect 
both the financial and human costs of providing 
care and families’ experiences. 
How to make a difference 
Healthcare Systems
Sands, the UK Stillbirth and Neonatal Death 
Society founded in 1978, recommends five key 
ways in which maternity units can improve 
the care for parents whose baby dies before, 
during or after birth (https://www.uk-sands.
org/professionals/principles-of-care/5-ways-
to-improve-care). These are (1) bereavement 
care training for all staff, (2) access to trained 
bereavement care midwives for bereaved 
parents and staff support, (3) at least one 
dedicated bereavement room, (4) bereavement 
care literature and (5) post mortem consent 
information for parents and staff training in 
consent.  This is because “the quality of care 
that bereaved families receive when their baby 
dies has long-lasting effects. Good care cannot 
remove parents’ pain and grief, but poor care 
can and does make things much worse.”
National clinical guidelines on the Investigation 
and Management of Late Fetal Intrauterine Death 
and Stillbirth were published in 2011, with 22 key 
recommendations setting out the expectation 
of standards of care in all Irish hospitals (http://
www.rcpi.ie/article.php?locID=1.5.71.492). 
The guideline highlights that skilled, sensitive 
and caring treatment in the time surrounding 
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pregnancy loss can positively impact on the 
grief experience of bereaved parents and 
recommends that supportive care should 
be made available to all. The introduction 
and, it is expected, implementation of these 
stillbirth guidelines ensures that, at a very 
minimum, parents should expect to receive 
comprehensive care, thorough investigation, 
and bereavement support from diagnosis to 
delivery and postnatally following stillbirth.
The HSE has recently launched a national public 
consultation process on draft Bereavement 
Care Standards following Pregnancy Loss 
& Perinatal Death, which, it is hoped, will 
be published in 2016 (http://www.hse.ie/
bereavementcarestandards/). These Standards 
are important to ensure improvements in 
key aspects of bereavement care for women, 
parents and families who experience stillbirth 
in Ireland, including the development of 
bereavement specialist teams in all maternity 
units and the provision of training and support 
for all healthcare professionals involved in 
caring for the bereaved.   
Stillbirth Research, Confidential Enquiries and 
Clinical Audit
Stillbirth is a highly significant topic of research. 
While stillbirth has been for decades a largely 
under-prioritised and under-researched 
problem, stillbirth research – that is, the 
investigation of causes of stillbirth as well 
as development of effective interventions to 
prevent stillbirth - has now been classified as a 
specific global research priority.  
Stillbirth has become an international focus of 
interest and concern as a preventable death, 
with the Global Alliance to Prevent Prematurity 
and Stillbirth (GAPPS) and the World Health 
Organization naming reduction in stillbirth rates 
as a key goal to improve pregnancy outcome. 
The Lancet’s Stillbirths Series listed stillbirth 
research priorities in 2011. These included: 
(i) developing repositories of human samples 
from stillbirths (ii) defining pathophysiological 
pathways leading to stillbirth associated with 
maternal disease, fetal growth restriction 
or placental dysfunction, (iii) investigating 
maternal lifestyle consumptions associated 
with stillbirth and (iv) determining optimal 
antenatal surveillance with interventions to 
reduce stillbirth. There has already been a 
significant increase in stillbirth research output 
commensurate with this attention, assisted by 
the increasing public awareness of the impact 
of perinatal grief. 
Consideration should be given to establishing 
a Confidential Enquiry into Perinatal Death 
in Ireland, in the same way as the Maternal 
Death Enquiry (MDE) Ireland has conducted 
confidential reviews into maternal deaths since 
2009. Confidential Enquiries focus on improving 
health care by collecting evidence on aspects 
of care, identifying any shortfalls in this, and 
disseminating recommendations based on 
these findings.  In this process, enquiry panels 
comprise clinicians from relevant specialties, 
who are independent of the hospital where 
the patient died and who are unaware of the 
clinicians concerned with the patient’s care. The 
purpose of a Confidential Enquiry is specific; 
identifying suboptimal patterns of practice and 
service provision related to the deaths, making 
recommendations for improvements in clinical 
care and suggesting directions for future 
research and audit.
Finally, robust perinatal audit is increasingly 
established throughout the developed world 
and aims to identify antecedent conditions 
and risk factors associated with stillbirth.  It 
has proved an important tool for reduction of 
perinatal mortality and assessment of quality 
of perinatal care. The work of the National 
Perinatal Epidemiology Centre in presenting the 
results of clinical audit in successive annual 
Perinatal Mortality Reports is therefore to be 
commended.
Acknowledgments 
The contribution of work by Rev. Daniel Nuzum, 
Ms. Orla O’Connell and Dr. Karen McNamara to 
this commentary is acknowledged. 
46  PERINATAL MORTALIT Y IN IREL AND ANNUAL REPORT 2013 
Keelin O’Donoghue PhD FRCOG
Senior Lecturer, Department of Obstetrics and Gynaecology, University College Cork
Consultant Obstetrician and Gynaecologist, Cork University Maternity Hospital
http://www.ucc.ie/en/obsgyn/plrg/
1. Badenhorst W, Hughes P. Psychological aspects of 
perinatal loss. Best Practice & Research Clinical Obstetrics & 
Gynaecology. 2007;21(2):249-59.
2. Bhutta ZA, Yakoob MY, Lawn JE, Rizvi A, Friberg IK, Weissman 
E, et al. Stillbirths: what difference can we make and at what 
cost? Lancet. 2011;377(9776):1523-38.
3. Cacciatore J. Psychological effects of stillbirth. Seminars in 
fetal & neonatal medicine. 2013;18(2):76-82.
4. Downe S, Schmidt E, Kingdon C, Heazell AE. Bereaved parents’ 
experience of stillbirth in UK hospitals: a qualitative interview 
study. BMJ open. 2013;3(2). Epub 2013/02/19.
5. Edrees H, Federico F.  Supporting clinicians after medical error. 
BMJ 2015;350:h1982 doi: 10.1136/bmj.h1982
6. Erlandsson K, Saflund K, Wredling R, Radestad I. Support after 
stillbirth and its effect on parental grief over time. Journal of 
social work in end-of-life & palliative care. 2011;7(2-3):139-52.
7. Ernst LM. A pathologists perspective on the perinatal autopsy. 
Seminars in perinatology. 2015;39(1):55-63.
8. Fallowfield L, Jenkins V. Communicating sad, bad, and difficult 
news in medicine. The Lancet. 2004;363(9405):312-9.
9. Flenady V, Boyle F, Koopmans L, Wilson T, Stones W, Cacciatore 
J. Meeting the needs of parents after a stillbirth or neonatal 
death. BJOG : an international journal of obstetrics and 
gynaecology. 2014;121 Suppl 4:137-40.
10. Flenady V, Froen JF, Pinar H, Torabi R, Saastad E, Guyon G, 
et al. An evaluation of classification systems for stillbirth. BMC 
pregnancy and childbirth. 2009;9:24.
11. Flenady V, Koopmans L, Middleton P, Froen JF, Smith GC, 
Gibbons K, et al. Major risk factors for stillbirth in high-income 
countries: a systematic review and meta-analysis. Lancet. 
2011;377(9774):1331-40.
12. Flenady V, Middleton P, Smith GC, Duke W, Erwich JJ, Khong 
TY, et al. Stillbirths: the way forward in high-income countries. 
Lancet. 2011;377(9778):1703-17.
13. Froen JF, Cacciatore J, McClure EM, Kuti O, Jokhio AH, 
Islam M, et al. Stillbirths 1 Stillbirths: why they matter. Lancet. 
2011;377(9774):1353-66.
14. Gold KJ, Kuznia AL, Hayward RA. How Physicians Cope With 
Stillbirth or Neonatal Death: A National Survey of Obstetricians. 
Obstetrics & Gynecology. 2008;112(1):29-34
15. Harper M, O’Connor RE, O’Carroll RC. Increased mortality 
in parents bereaved in the first year of their child’s life. BMJ 
Supportive & Palliative Care. 2011.
16. Heazell AE, Martindale EA. Can post-mortem examination 
of the placenta help determine the cause of stillbirth? Journal 
of obstetrics and gynaecology : the journal of the Institute of 
Obstetrics and Gynaecology. 2009;29(3):225-8.
17. Heaazell A, Siassakos D; Blencowe H; Bhutta ZA; Cacciatore J; 
Dang N; Das J; Flenady VJ; Gold KJ; Mensah OK; Millum L; Nuzum 
D; O’Donoghue K; Redshaw M; Rizvi A; Roberts T; Saraki T; Storey 
C; Wojciesek A; Downe S. Stillbirth: Why Invest?. The Lancet (in 
press; August 2015)
18. Institute of Obstetricians and Gynaecologists RCPI, 
Directorate of Strategy and Clinical Programmes HSE. 
Investigation and Management of Late Fetal Intrauterine Death 
and Stillbirth. 1.0 ed. Dublin: Health Services Executive; 2011.
19. Kearney MK, Weininger RB, Vachon MLS, Harrison RL, Miunt 
BM.  Self-care for physicians caring for patients at the end of life. 
JAMA. 2009;301(11):1155-1164
20. Kelley MC, Trinidad SB. Silent loss and the clinical encounter: 
Parents’ and physicians’ experiences of stillbirth-a qualitative 
analysis. BMC pregnancy and childbirth. 2012;12:137. Epub 
2012/11/28.
21. Koopmans L, Wilson T, Cacciatore J, Flenady V. Support 
for mothers, fathers and families after perinatal death. The 
Cochrane database of systematic reviews. 2013;6: CD000452.
22. Lawn et al. Global report on preterm birth and stillbirth (1 of 
7): definitions, description of the burden and opportunities to 
improve data.  BMC Pregnancy and Childbirth 2010, 10 (Suppl 
1):S1 
23. Leoni LC, Woods JR, Woods JE. Caring for patients after 
pregnancy loss. AWHONN lifelines/Association of Women’s 
Health, Obstetric and Neonatal Nurses. 1998;2(1):56-8. 
24. Manktelow BM, Smith LK, Evans TA, Hyman-Taylor P, 
Kurinczuk JJ, Field DJ, Smith PW, Draper ES, on behalf of the 
MBRRACE-UK collaboration. Perinatal Mortality Surveillance 
Report UK Perinatal Deaths for births from January to December 
2013. Leicester: The Infant Mortality and Morbidity Group, 
Department of Health Sciences, University of Leicester. 2015.
25. Meaney S, Gallagher S, Lutomski JE, O’Donoghue K. Parental 
decision making around perinatal autopsy: a qualitative 
investigation. Health expectations. 2014. Epub 2014/11/08.
26. Medical Council of Ireland.  Your Training  Counts: spotlight on 
health and wellbeing.  Medical Council, Dublin, 2014
27. Mistry H, Heazell AE, Vincent O, Roberts T. A structured review 
and exploration of the healthcare costs associated with stillbirth 
and a subsequent pregnancy in England and Wales. BMC 
pregnancy and childbirth. 2013;13:236.
28. Monari F and Facchinetti F. Management of subsequent 
pregnancy after antepartum stillbirth; a review. J Matern Fet 
Neonat Med 2010; 23 (10): 1073-84
29. Nordlund E, Börjesson A, Cacciatore J, Pappas C, Randers 
I, Rådestad I. When a baby dies: Motherhood, psychosocial 
care and negative affect. British Journal of Midwifery. 
2012;20(11):780-4.
30. Nuzum D, Meaney S, O’Donoghue K. The impact of stillbirth 
on consultant obstetrician gynaecologists: a qualitative study. 
BJOG : an international journal of obstetrics and gynaecology. 
2014;121(8):1020-8.
31. Nuzum D, Meaney S, O’Donoghue K. The provision of spiritual 
and pastoral care following stillbirth in Ireland: a mixed methods 
study. BMJ Support Palliat Care. 2014.
32. Puia DM, Lewis L, Beck CT. Experiences of obstetric nurses 
who are present for a perinatal loss. Journal of obstetric, 
gynecologic, and neonatal nursing : JOGNN / NAACOG. 
2013;42(3):321-31. Epub 2013/05/21.
33. Radestad I, Steineck G, Nordin C, Sjogren B. Psychological 
complications after stillbirth—influence of memories and 
immediate management: population based study. BMJ. 
1996;312(7045):1505-8.
34. Saflund K, Sjogren B, Wredling R. The role of caregivers 
after a stillbirth: views and experiences of parents. Birth. 
2004;31(2):132-7. Epub 2004/05/22.
35. Schott J, Henley A, Kohner N.  Pregnancy Loss and the Death 
of a Baby. Guidelines for professionals.. 3rd ed. London: Bosun 
Press, on behalf of SANDS; 2007
36. Stillbirth Collaborative Research Network Writing G. Causes 
of death among stillbirths. JAMA. 2011;306(22):2459-68.
37. Thieleman K, Cacciatore J.  Witness to suffering: Mindfulness 
andCompassion Fatigue among Traumatic Bereavement 
Volunteers and Professionals.  Social Work 2014; 59 (1): 34-41
38. Vincent C. Understanding and responding to adverse events. 
NEJM 2003; 348 (11): 1051-5
39. Warland J, O’Leary J, McCutcheon H, Williamson V. 




3. Stillbirths: Specific findings
Figure 3.1: Primary cause of death in stillbirths (left-hand chart) and detailed cause in cases of major congenital 
anomaly (right-hand chart)
Cause of death in stillbirths
Major congenital anomaly was the primary cause 
of death in almost one in four (n=69, 22.9%) of the 
301 stillbirths that occurred in 2013 (Figure 3.1). 
There was a chromosomal disorder in almost half 
of the 69 stillbirths due to congenital anomaly 
(n=33, 47.8%). In these cases, the majority were 
diagnosed by cytogenetic analysis (n=23, 69.7%). 
Anomalies of the central nervous system and of the 
cardiovascular system caused a further 10 (14.5%) 
and nine (13.0%) stillbirths, respectively.
Specific placental conditions were diagnosed in two-
thirds (66.3%) of stillbirth cases and a placental 
condition, most commonly placental insufficiency, 
was classified as the main cause of death of almost 
one in four stillbirths (n=66, 21.9%). One in ten 
stillbirths (n=30, 10.0%) were due to mechanical 
factors, the vast majority of which were due to the 
umbilical cord being around the baby’s neck or 
another entanglement or knot in the umbilical cord. 
Antepartum or intrapartum haemorrhage was the 
 
main cause of death in 26 cases of stillbirth (8.6%) 
and placental abruption was involved in all of these 
cases. For the 17 stillbirths with infection as the main 
cause of death, half involved chorioamnionitis (n=9).
For approximately one in four stillbirths (n=71, 
23.6%) the cause of death was unexplained. While 
this is significantly lower than the proportion 
previously reported as unexplained using the 
Wigglesworth Classification System, it is marginally 
higher than in the two previous years. For half of 
the stillbirths of unexplained cause (n=36, 50.7%), 
antecedents or associated obstetric factors were 
present but did not cause the death. For more than 
one third of unexplained stillbirths (n=26, 36.6%), 
it was reported that there were no antecedents or 
associated obstetric factors. For all but one of these 
26 cases an autopsy was performed (n=12, 46.2%) 
or was offered (n=13, 50.0%). A detailed listing of the 
main cause of death for the 301 stillbirths is given at 
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Factors influencing the delivery management 
of women experiencing antepartum stillbirths 
include maternal choice, maternal wellbeing, 
risk of developing severe medical complications 
and previous obstetric history. Management of 
clinical care may involve planned induction of 
labour, awaiting spontaneous labour or in some 
cases elective delivery by caesarean section.40
In 2013, labour was induced for two-thirds of 
the 269 women who experienced antepartum 
stillbirth (n=175, 65.1%) whereas labour was 
spontaneous for 24.2% (n=65). It can be seen 
from Figure 3.2 that the time from diagnosis 
of fetal demise to delivery was different for 
women whose labour was induced than it was 
for women whose labour was spontaneous. The 
confirmation of death and delivery took place 
on the same day for three quarters (n=63 of 
84, 75.0%) of the women whose labour was 
spontaneous. For women whose labour was 
induced, it was common for up to three days to 
pass between diagnosis and delivery.
               
Figure 3.2: Time from confirmation of fetal demise to stillbirth delivery for women with induced and spontaneous labour
40 Clinical Practice Guideline No 4 (2011). Investigation and management of late fetal intrauterine death and stillbirth: 
Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical 
Programmes, Health Service Executive.
41 Clinical Practice Guideline No 4 (2011). Investigation and management of late fetal intrauterine death and stillbirth: 
Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical 
Programmes, Health Service Executive.
Management of women experiencing antepartum stillbirths
Vaginal birth is the recommended mode of delivery 
for most women experiencing antepartum 
stillbirth, but caesarean section may be clinically 
indicated in some cases.41 Spontaneous vaginal 
delivery was the mode of delivery in more than 
two-thirds of cases of antepartum stillbirth 
(70.6%) compared to approximately half of the 
cases of intrapartum stillbirth (n=13, 54.2%).
In 24 cases of antepartum stillbirth (9.1%) the 
intended mode of delivery was a planned caesarean 
section and ultimately, caesarean section was 
the mode of delivery for 34 women (12.6%; 28 
pre-labour caesarean sections and six caesarean 
sections performed after onset of labour).
Of the 34 women who were delivered by caesarean 
section, the indication for caesarean section 
was classified as ‘elective’ in approximately 40% 
of the cases, 30% were ‘urgent’ and 30% were 
‘emergency’ (Table 3.1). Thirteen (38.2%) of the 34 
women had a caesarean section previously, one 
in three (n=11, 33.3%; unknown for one case) had 
a multiple delivery and eight (25.0%; unknown for 
two cases) had a placental abruption, all factors 
that may have influenced the mode of delivery.
The location of delivery of antepartum stillbirths 
in all but two cases (n=267, 99.3%) was in 
obstetric-led maternity units. The two exceptions 
were born before arrival to hospital.
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Indication for caesarean section n(%)
Elective: At a time to suit the woman or the maternity team 13(39.4)
Urgent: Maternal or fetal compromise which is not immediately life threatening 10(30.3)
Emergency: Immediate threat to life of woman or baby 10(30.3)
Table 3.1: Indication for caesarean section in women experiencing antenatal stillbirth in 2013
42 Darmstadt G, Yakoob M, Haws R, Menezes E, Soomro T and Bhutta Z. Reducing stillbirths: interventions during labour. BMC 
Pregnancy and Childbirth 2009;9 (Suppl 1):s6
43 Manktelow BM, Smith LK, Evans TA, Hyman-Taylor P, Kurinczuk JJ, Field DJ, Smith PW, Draper ES, on behalf of the MBRRACE-
UK collaboration. Perinatal Mortality Surveillance Report UK Perinatal Deaths for births from January to December 2013. 
Leicester: The Infant Mortality and Morbidity Group, Department of Health Sciences, University of Leicester. 2015.
Of the 24 intrapartum deaths, 10 (41.7%) 
were due to major congenital anomaly and 
four (16.7%) were due to placental abruption. 
Conditions related to the umbilical cord and to 
the placenta each caused another two cases. In 
three cases the cause of death was classified 
as unexplained though some antecedent or 
associated obstetric factors were reported. 
There was no clustering by hospital in the 
intrapartum deaths due to causes other than 
congenital anomaly. It was reported that a 
local hospital review was undertaken into 10 
of the 24 intrapartum deaths (41.7%).
Intrapartum stillbirths
It has been suggested that the comparatively 
low proportion of intrapartum stillbirths in 
high-income countries indicates that fetal 
deaths occurring in labour, in non-anomalous 
babies, are most likely preventable with quality 
intrapartum care.42 Intrapartum deaths in this 
audit were identified by a specific question 
on the NPEC Perinatal Death Notification Form 
as to whether the baby was alive at the onset 
of care in labour. This was not known in eight 
cases (Table 3.2), four of which involved the 
baby being born before arrival to hospital. There 
were 24 cases of stillbirth where the baby was 
known to be alive at the onset of care in labour. 
Thus, intrapartum deaths accounted for 8.0% 
of stillbirths in Ireland in 2013. This was lower 
than the proportion of stillbirths associated 
with labour in UK countries in 2013, ranging 
from 8.4% in England to 8.6% in Northern 
Ireland, 10.9% in Wales and 13.2% in Scotland.43
 n(%)
Baby alive at onset of care in labour 24(8.0%)
Baby not alive at onset of care in labour 256(85.0%)
Never in labour 13(4.3%)
Not known 8(2.7%)
Table 3.2: Life status of baby at the onset of care in labour for stillbirths in 2013
Note: Indication unknown in one case
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Table 3.3: Stillbirth main cause of death in 2011-2013, NPEC Classification System
Stillbirths 2011 2012 2013
   N=318 N=304 N=301
Major congenital anomaly 81(25.5%) 80(26.3%) 69(22.9%)
 Central nervous system 10 11 10
 Cardiovascular system 10 5 9
 Respiratory system - 1 1
 Gastro-intestinal system 3 2 2
 Musculo-skeletal system 3 1 1
 Multiple anomalies 10 10 5
 Chromosomal disorders 39 38 33
 Metabolic disorders - - -
 Urinary tract 2 2 6
 Other major congenital anomaly 4 10 2
Specific placental conditions 52(16.4%) 73(24.0%) 66(21.9%)
 Maternal vascular malperfusion*   22
 Fetal vascular malperfusion*   16
 Cord pathology*   9
 Placental maturation defect*   8
 Chorioamnionitis, placenta - - 1
 Villitis - 4 2
 Other placental condition 19 20 8
Mechanical 20(6.3%) 25(8.2%) 30(10.0%)
 Prolapse cord 1 1 2
 Cord around neck 8 14 18
 Other cord entanglement or knot 11 10 9
 Uterine rupture before labour - - 1
 Uterine rupture during labour - - -
 Mal-presentation - - -
 Shoulder dystocia - - -
Antepartum or intrapartum haemorrhage 35(11.0%) 21(6.9%) 26(8.6%)
 Praevia 2 - -
 Abruption 33 21 26
 Uncertain haemorrhage - - -
*Reported abnormal placental histology was not classified under these categories for the years 2011 and 2012; Placental 
maturation defect includes distal villous immaturity and delayed villous maturation.
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Table 3.3: Stillbirth main cause of death in 2011-2013, NPEC Classification System (Contd.)
Stillbirths 2011 2012 2013
 N=318 N=304 N=301
Infection 17(5.3%) 16(5.3%) 17(5.6%)
Maternal   
    Bacterial 1 - -
    Syphilis 1 - -
    Viral diseases - 2 1
    Protozoal - - -
    Group B Streptococcus 2 1 3
    Other maternal infection - - 1
Ascending infection   
    Chorioamnionitis 13 11 9
    Other ascending infection - 2 3
Specific fetal conditions 15(4.7%) 9(3.0%) 14(4.7%)
    Twin-twin transfusion 5 4 6
    Feto-maternal haemorrhage 5 2 4
    Non immune hydrops 3 - 1
    Iso-immunisation - - -
    Other fetal condition 2 3 3
Intra-uterine growth restriction 17(5.3%) 6(2.0%) 5(1.7%)
    IUGR - Suspected antenatally 4 4 2
    IUGR - Observed at delivery 7 1 1
    IUGR - Observed at post mortem 6 1 2
Associated obstetric factors 7(2.2%) 3(1.0%) 2(0.7%)
    Intracranial haemorrhage - - -
    Birth injury to scalp - - -
    Fracture - - -
    Other birth trauma - - -
    Intrapartum asphyxia 5 - -
    Polyhydramnios - - -
    Oligohydramnios - - -
    Premature rupture of membranes - - -
    Spontaneous premature labour - 2 2
    Other obstetric factors 2 1 -
Maternal disorder 6(1.9%) 0(0.0%) 1(0.3%)
    Pre-existing hypertensive disease 1 - -
    Diabetes 2 - -
    Other endocrine conditions - - -
    Thrombophilias - - -
    Obstetric cholestasis - - -
    Drug misuse - - -
    Uterine anomalies 1 - -
    Other maternal disorder 2 - 1
Hypertensive disorders of pregnancy 4(1.3%) 2(0.7%) 0(0.0%)
    Pregnancy induced hypertension 1 - -
    Pre-eclampsia toxaemia 3 2 -
    HELLP syndrome - - -
    Eclampsia - - -
Unexplained 64(20.1%) 69(22.7%) 71(23.6%)
    No antecedents or associated obstetric factors 41 30 26
    Antecedents or associated obstetric factors present 20 38 36
    Very limited information available - - 4
    Pending post mortem or other investigation 3 1 5

















Cause of early neonatal death
The cause of early neonatal deaths was classified 
using both the NPEC Neonatal Classification 
System and the NPEC Maternal and Fetal 
Classification System in order to identify both 
the primary neonatal condition causing the 
death and the underlying main antecedent or 
obstetric factor associated with the death.
Major congenital anomaly was the primary 
cause of death of more than half (n=92, 56.8%) 
of the 162 early neonatal deaths (Figure 4.1). 
Respiratory disorder was the only other common 
main cause of death, accounting for one in 
three (n=53, 32.7%) early neonatal deaths. 
Neurological disorder was the main cause in 
6.2% of cases. One death (0.6%) was unexplained 
pending post mortem or other investigation. A 
detailed listing of the main cause of death for the 
162 early neonatal deaths is given at the end of 
this section of the report.
4. Early neonatal deaths: Specific findings
Figure 4.1: Primary cause of early neonatal death (upper chart) and detailed cause in cases of respiratory disorder 













The type of major congenital anomaly that 
caused 92 of the 162 neonatal deaths is 
illustrated in Figure 4.1. One in four were due 
to a chromosomal disorder (n=25, 27.2%), one 
in five (n=19, 20.7%) were due to anomalies 
related to the central nervous system and 
a similar proportion were due to multiple 
abnormalities (n=17, 18.5%). Anomalies of 
the cardiovascular system and of the urinary 
tract each accounted for a further 10% of these 
deaths. For most of the 25 neonatal deaths 
attributed to a chromosomal disorder the 
diagnosis was made by cytogenetic analysis 
(n=15, 60.0%).
Respiratory disorders
Of the 53 early neonatal deaths caused by 
respiratory disorder, 60% (n=32, 60.4%) 
were due to severe pulmonary immaturity. 
Surfactant deficiency lung disease caused 
14 neonatal deaths (Figure 4.1). All but three 
of the 53 early neonatal deaths attributed 
to respiratory disorder occurred in babies 
delivered before 28 weeks gestation (Table 
4.1). This pattern of gestational age was in 
marked contrast with the early neonatal 
deaths due to major congenital anomaly and 
those due to other causes (Table 4.1).
Neurological disorders
A neurological disorder was attributed as the 
main cause of ten early neonatal deaths. For 
nine of these cases, the condition involved 
was hypoxic ischaemic encephalopathy 
(HIE). Four of the nine HIE cases occurred in 
babies with a gestational age of 37-41 weeks. 
These four perinatal deaths had an autopsy 
performed and became coroner’s cases. Table 
4.2 details the gestational age, customised 
birthweight centile and main antecedent or 
obstetric factor associated with the ten early 
neonatal deaths attributed to neurological 
disorders.
Broad main cause of death <22 22-27 28-31 32-36 37-41 ≥42 
 weeks weeks weeks weeks weeks weeks
Respiratory disorder 1 49 2 1 - -
 (1.9%) (92.5%) (3.8%) (1.9%)  
Major congenital anomaly - 9 4 41 36 2
  (9.8%) (4.3%) (44.6%) (39.1%) (2.2%)
Other 1 4 1 6 4 -
 (6.3%) (25.0%) (6.3%) (37.5%) (25.0%) 
Table 4.1: Gestational age distribution in neonatal deaths by broad main cause of death in 2013
Neurological  Gestational age  Birthweight centile Main antecedent or obstetric factor 
Disorder   associated with the death
IVH/PVH 23 8th Spontaneous premature labour
HIE 34 52nd Fetal vascular malperfusion
HIE 36 31st Placental abruption
HIE 36 72nd Placental abruption
HIE 35 16th Maternal vascular malperfusion
HIE 35 93rd Placental maturation defect
HIE 40 2nd Placental maturation defect
HIE 40 69th Fetal vascular malperfusion
HIE 40 20th Intrapartum uterine rupture
HIE 41 14th Cord pathology
Note: IVH/PVH = Intraventricular/periventricular haemorrhage; HIE = hypoxic ischaemic encephalopathy
Table 4.2: Details of early neonatal deaths due to neurological disorders in 2013
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Condition and management at birth
The NPEC Perinatal Death Notification Form 
records the condition, in terms of respiratory 
activity and heart rate shortly after delivery, of 
babies who die in the neonatal period. For most 
of these babies (n=93, 58.5%; unknown for 
three cases), spontaneous respiratory activity 
was absent or ineffective at five minutes 
following delivery and for 40% (n=64, 40.5%, 
unknown for four cases) the heart rate was 
persistently less than 100 beats per minute.
In most cases of early neonatal death, active 
resuscitation was offered in the delivery room 
(Table 4.3). In three quarters of the cases 
where active resuscitation was not offered 
(n=50, 73.5%) major congenital anomaly 
was the cause of death and all but two of 
the remainder were attributed to severe 
pulmonary immaturity (n=16, 23.5%).
Almost half of the babies were admitted to a 
neonatal unit in the hospital of delivery and 
one in ten babies were transferred to another 
unit (Table 4.3). Such admission and transfer 
depended on whether active resuscitation had 
been offered in the delivery room. Admission to 
a neonatal unit followed three quarters of the 
cases offered active resuscitation compared 
to 7% not offered active resuscitation. One in 
seven cases offered active resuscitation were 
transferred to another unit compared to one 
baby not offered active resuscitation.
Management Active resuscitation offered * All
 Yes (91, 57.2%) No (68, 42.8%) 162
Baby admitted to neonatal unit 71 (78.0%) 5 (7.4%) 78 (48.1%)
Baby transferred to another unit 13 (14.3%) 1 (1.5%) 17 (10.5%)
*active resuscitation in the delivery room includes BMV, PPV, intubation, cardiac massage. 
Note: Data on active resuscitation was unknown for three cases.
Table 4.3: Management of neonate at birth who subsequently died within the first week of life
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Age of neonate at death
Two thirds of the early neonatal deaths 
occurred within 24 hours of delivery (Table 
4.4). Major congenital anomaly and severe 
pulmonary immaturity were the main cause 
of death in 58.9% (n=63) and 26.2% (n=28) of 
these cases, respectively.
Completed days 0 1 2 3 4 5 6
Number 107 25 13 4 3 8 2
% 66.0 15.4 8.0 2.5 1.9 4.9 1.2
Cumulative % 66.0 81.5 89.5 92.0 93.8 98.8 100.0
Table 4.4: Age of neonate at death
Location of neonatal death
The vast majority of early neonatal deaths 
occurred either in the labour ward, in another 
maternity unit ward or in the neonatal unit 
(Table 4.5). Less than one in ten deaths 
occurred in a paediatric centre.
Place of death n(%)
At home/in transit before arrival at a maternity unit 3(1.9%)
Labour ward 64(39.5%)
Neonatal unit 68(42.0%)
Ward of the maternity unit 16(9.9%)
Paediatric centre 9(5.6%)
At home/in transit after delivery in a maternity unit 2(1.2%)
Table 4.5: Location of neonatal death
All 64 neonatal deaths that occurred in the 
labour ward occurred within 24 hours of 
delivery. These 64 deaths in the labour ward 
accounted for 60% (59.8%) of the 107 neonatal 
deaths that occurred in the first day. A further 
23.4% (n=25) first day neonatal deaths 
occurred in a neonatal unit. As detailed in Table 
4.4, the daily number of neonatal deaths was 
significantly lower once 24 hours had elapsed 
after delivery. Three quarters of the neonatal 
deaths after 1-6 completed days happened in a 
neonatal unit (n=43 of 53, 78.2%) and a further 
one in eight of these deaths (n=7, 12.7%) 
happening in a paediatric centre (Figure 4.2).
Figure 4.2: Place of neonatal death 0-6 complete days after birth
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Table 4.6: Early neonatal main cause of death in 2011-2013, NPEC Classification System
 2011 2012 2013
 N=138 N=141 N=162
Major congenital anomaly 71(51.4%) 68(48.2%) 92(56.8%)
Central nervous system 15 7 19
Cardiovascular system 8 7 9
Respiratory system 2 2 1
Gastro-intestinal system 2 2 2
Musculo-skeletal system 2 2 1
Multiple anomalies 8 12 17
Chromosomal disorders 20 17 25
Metabolic disorders (in-born errors of metabolism) 1 2 -
Urinary tract 6 13 9
Other major congenital anomaly 7 4 9
Pre-viable (<22 weeks) - 1(0.7%) 1(0.6%)
Respiratory disorders 45(32.6%) 44(31.2%) 53(32.7%)
Severe pulmonary immaturity 39 29 32
Surfactant deficiency lung disease - 9 14
Pulmonary hypoplasia 3 1 2
Meconium aspiration syndrome - - -
Primary persistent pulmonary hypertension - 1 -
Chronic lung disease/bronchopulmonary dysplasia - - -
Other respiratory disorder 3 4 5
Gastro-intestinal disease 1(0.7%) 3(2.1%) 1(0.6%)
Necrotising enterocolitis 1 2 1
Other gastro-intestinal disease - 1 -
Neurological disorder 7(5.1%) 14(9.9%) 10(6.2%)
Hypoxic-ischaemic encephalopathy 6 10 9
Intraventricular/periventricular haemorrhage - 2 1
Other neurological disorder 1 2 -
Infection 6(4.3%) 4(2.8%) 3(1.9%)
Sepsis 4 2 1
Pneumonia - 1 1
Meningitis - - -
Other infection 2 1 1
Injury/Trauma - - -
Other specific causes 2(1.4%) 3(2.1%) 1(0.6%)
Malignancies/tumours - - -
Other specific cause 2 3 1
Sudden unexpected deaths 1(0.7%) 2(1.4%) -
Sudden infant death syndrome (SIDS) 1 2 -
Infant Deaths - Cause Unascertained - - -
Unexplained 5(3.6%) 2(1.4%) 1(0.6%)
No antecedents or associated obstetric factors - 1 -
Antecedents or associated obstetric factors present - - -
Very limited information available 5 - -
Pending post mortem or other investigation - 1 1
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The investigation of perinatal deaths due to 
intrapartum events is valuable in assessing 
quality of care. These deaths are unexpected 
and include stillbirths alive at the onset of 
professional care in labour and neonatal 
deaths. Traditionally intrapartum deaths 
referred to babies who were alive at onset 
of labour but stillborn. The inclusion of 
neonatal deaths facilitates the assessment 
of all perinatal deaths that may have an 
intrapartum origin.
We reviewed perinatal deaths reported for 
2011, 2012 and 2013 focusing on babies 
with a gestational age of at least 34 weeks 
and a birthweight of at least 2,500g and 
whose death was not due to major congenital 
anomaly, infection or placental abruption. 
In total, there were 35 such deaths in 2011-
2013 suggesting a rate of 0.16 per 1,000 
births (95% confidence interval: 0.11-0.22 per 
1,000) or one in 6,148 births in Ireland. The 
35 deaths occurred in 14 of the 20 maternity 
units operating in the country in 2011-2013. 
The unit-specific numbers are too small to 
draw conclusions regarding outliers.
Eleven deaths occurred in 2011 (six stillbirths 
and five early neonatal deaths), 13 occurred 
in 2012 (two stillbirths and 11 early neonatal 
deaths) and 11 occurred in 2013 (three 
stillbirths and eight early neonatal deaths). A 
post mortem was undertaken for all 11 deaths 
in 2013 and all were coroner cases. Details of 
the cases are provided in Table 5.1.
5. Perinatal deaths associated with intrapartum events
Type of Gestational age Birthweight Main antecedent or Neonatal cause
perinatal (weeks) centile obstetric factor of death
death   associated with the death
SB 38 58th Intra pulmonary haemorrhage Not applicable
SB 40 92nd Placental maturation defect Not applicable
SB 40 51st Unexplained cause1 Not applicable
ENND 36 11th No antenatal care, unattended home Respiratory
   delivery, PROM, Chorioamnionitis Disorder
ENND 35 93rd Placental maturation defect HIE
ENND 40 2nd Placental maturation defect HIE
ENND 34 52nd Fetal vascular malperfusion HIE
ENND 40 69th Fetal vascular malperfusion HIE
ENND 41 14th Cord pathology HIE
ENND 40 20th Intrapartum uterine rupture HIE
ENND Unknown Unknown Late booker, unattended home  HIE
   delivery,  unexplained cause2 
Note: SB=Stillbirth; ENND=Early neonatal death; Unexplained cause1=some antecedents or associated obstetric factors; Unexplained cause2=pending 
results of coroner’s post mortem; PROM=Premature rupture of membranes; HIE=hypoxic ischaemic encephalopathy
Table 5.1: Details of perinatal deaths in 2013 associated with intrapartum events
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Data relating to 37 late neonatal deaths 
occurring in 2013 were reported to the 
NPEC for the purposes of this clinical audit. 
At the time of writing finalised figures for 
late neonatal deaths in 2013 were not yet 
published by the Central Statistics Office 
(CSO). In the five most recent years for which 
data are available, 2008-2012, the annual 
number of late neonatal deaths fluctuated 
between 29 and 41 with no discernible trend. 
For the year 2012, there were 40 late neonatal 
deaths according to the published CSO figures 
and 40 late neonatal deaths were reported to 
the NPEC. Thus, the numbers reported to the 
NPEC are consistent with the CSO figures for 
recent years. However, maternity hospitals 
may not be notified of the late neonatal death 
of a baby delivered in their unit if the baby was 
transferred to a paediatric unit or discharged 
home. The NPEC is working with colleagues 
in the relevant hospitals (maternity and 
paediatric) and in the National Office of 
Clinical Audit to address this issue.
Given the notification issue and the limited 
number of late neonatal deaths reported, this 
section of the report provides a brief summary 
of the submitted data as well as the detailed 
listing of the main cause of the 37 deaths 
according to the NPEC Classification System.
Similar to early neonatal deaths, approximately 
half of late neonatal deaths were due to major 
congenital anomaly (n=18, 48.6%). The next 
most common causes were neurological 
disorders (n=7, 18.9%), respiratory disorders 
(n=5, 13.5%) and sudden infant death 
syndrome (n=4, 10.8%). The main cause of 
one late neonatal death was unexplained 
pending post mortem or other investigation.
Table 6.1 describes a range of characteristics 
of the babies who died in the late neonatal 
period. Most of the babies who died in the late 
neonatal period were male. This fluctuates 
from year to year. There were similar 
proportions of male (n=18, 45.0%) and female 
(n=22, 55.0%) babies among those who died 
in the late neonatal period in 2012 whereas in 
2011 three quarters of the babies were male 
(n=26 of 35, 74.3%).
Half of the babies who died in the late neonatal 
period in 2013 were born by spontaneous 
vaginal delivery and 43% were delivered by 
caesarean section. Most had a gestational 
age of at least 37 weeks at birth but almost 
half (n=17, 45.9%) had a birthweight less than 
2,500 grams. One in five of the babies were 
small for gestational age (SGA; <10th centile).
Previous reports have shown that the 
proportion of late neonatal deaths decreases 
across the second, third and fourth weeks of 
life. This was not the case in 2013 as 40.5%, 
24.3% and 35.1% died in weeks two, three and 
four, respectively (Table 6.1).
Most late neonatal deaths in 2013 occurred 
in the neonatal unit and one in four died in a 
paediatric centre.
6. Late neonatal deaths: Specific findings
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Table 6.1: Characteristics of late neonatal deaths, 2012-2013
  2012, N=40 2013, N=37
Infant sex  
 Male 18 (45.0) 22 (59.5)
 Female 22 (55.0) 15 (40.5)
Mode of delivery  
 Spontaneous vertex delivery 22 (5.0) 18 (48.6)
 Pre-labour caesarean section 10 (25.0) 9 (24.3)
 Caesarean section after onset of labour 4 (10.0) 7 (18.9)
 Forceps 1 (2.5) -
 Assisted breech 2 (5.0) 2 (5.4)
 Ventouse 1 (2.5) 1 (2.7)
Gestational age at delivery  
 22-27 weeks 15 (37.5) 11 (29.7)
 28-31 weeks 1 (2.5) 3 (8.1)
 32-36 weeks 6 (15.0) 2 (5.4)
 37-41 weeks 18 (45.0) 21 (56.8)
Birthweight  
 500<1000g 16 (40.0) 11 (29.7)
 1000<1500g - 1 (2.7)
 1500<2000g 5 (12.5) 3 (8.1)
 2000<2500g 6 (15.0) 2 (5.4)
 2500<3000g 5 (12.5) 7 (18.9)
 3000<3500g 4 (10.0) 7 (18.9)
 3500<4000g 1 (2.5) 5 (13.5)
 4000g+ 3 (7.5) 1 (2.7)
Customised birthweight centile category  
 Zero 10 (25.0) 2 (5.4)
 <3rd 13 (32.5) 3 (8.1)
 <10th 17 (42.5) 8 (21.6)
 10-49th 13 (32.5) 16 (43.2)
 50-89th 6 (15.0) 11 (29.7)
 90th+ 4 (10.0) 2 (5.4)
Timing of death  
 2nd week of life 23 (57.5) 15 (40.5)
 3rd week of life 10 (25.0) 9 (24.3)
 4th week of life 7 (17.5) 13 (35.1)
Location of death  
 Home (after delivery in a maternity unit) 6 (15.0) 5 (13.5)
 Ward of the maternity unit 1 (2.5) 1 (2.7)
 Neonatal unit 18 (45.0) 21 (56.8)
 In transit home 1 (2.5) -
 Paediatric centre 14 (35.0) 10 (27.0)
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Table 6.2: Late neonatal main cause of death in 2011-2013, NPEC Classification System
  2011 2012 2013
  N=35 N=40 N=37
Major congenital anomaly 20(57.1%) 15(37.5%) 18(48.6%)
Central nervous system 2 2 2
Cardiovascular system 5 5 4
Respiratory system 1 1 -
Gastro-intestinal system 1 - 1
Musculo-skeletal system 1 - 1
Multiple anomalies 1 2 3
Chromosomal disorders 6 4 4
Metabolic disorders - - 1
Urinary tract - - 1
Other major congenital anomaly 3 1 1
Pre-viable (<22 weeks) - - -
Respiratory disorders 5(14.3%) 9(22.5%) 5(13.5%)
Severe pulmonary immaturity 5 5 4
Surfactant deficiency lung disease - 1 -
Pulmonary hypoplasia - - -
Meconium aspiration syndrome - - -
Primary persistent pulmonary hypertension - - -
Chronic lung disease/bronchopulmonary dysplasia - - 1
Other respiratory disorder - 3 -
Gastro-intestinal disease 2(5.7%) 6(15.0%) 1(2.7%)
Necrotising enterocolitis 2 5 1
Other gastro-intestinal disease - 1 -
Neurological disorder 2(5.7%) 1(2.5%) 7(18.9%)
Hypoxic-ischaemic encephalopathy 1 - 3
Intraventricular/periventricular haemorrhage - - 4
Other neurological disorder 1 1 -
Infection 4(11.4%) 4(10.0%) 1(2.7%)
Sepsis 4 3 1
Pneumonia - - -
Meningitis - - -
Other infection - 1 -
Injury/Trauma - - -
Other specific causes - - -
Malignancies/tumours - - -
Other specific cause - - -
Sudden unexpected deaths - 3(7.5%) 4(10.8%)
Sudden infant death syndrome (SIDS) - 3 4
Infant Deaths - Cause Unascertained - - -
Unexplained 2(5.7%) 2(5.0%) 1(2.7%)
No antecedents or associated obstetric factors - - -
Antecedents or associated obstetric factors present - - -
Very limited information available 2 2 -
Pending post mortem or other investigation - - 1
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While not included in the calculation of 
perinatal mortality rates, we ask for notification 
of deaths in the early neonatal period of 
babies born before 24 weeks gestation and 
weighing less than 500g. For 2013, 41 such 
deaths were reported by six maternity units. 
These maternity units accounted for almost 
60% (58.9%) of births in Irish maternity 
units in 2013. Using this proportion would 
give a national estimate for 2013 of 70 early 
neonatal deaths of babies born before 24 
weeks gestation with a birthweight less than 
500g.
Using the NPEC Neonatal Classification 
System, the assigned cause of death was 
pre-viable (<22 weeks) for 25 cases (61.0%) 
and severe pulmonary immaturity for the 
other 16 cases (39.0%). Based on the NPEC 
Maternal and Fetal Classification System, 
the antecedent or associated obstetric 
factors in these 41 early neonatal deaths 
were spontaneous premature labour (n=25, 
61.0%), ascending infection (n=12, 29.3%), 
specific placental conditions (n=3, 7.3%) 
and premature rupture of membranes (n=1, 
2.4%).
The birthweights of the babies were in the 
range 205-495g and their gestation at delivery 
was 17-23 weeks. The evidence of fetal growth 
restriction was limited as indicated by the 
customised birthweight centiles calculated 
for 38 of the 41 babies. Six (15.8%) were 
small-for-gestational-age (SGA; <10th centile) 
and four (10.5%) severely SGA (<3rd centile). 
However, close to 90% (n=32 of 38, 84.2%) 
were above the 10th centile.
All died within 24 hours of being delivered, 
most commonly in the labour ward (n=29, 
70.7%) but in some cases in another ward of 
the maternity unit (n=12, 29.3%). For 33 of the 
41 babies (80.5%), spontaneous respiratory 
activity was absent or ineffective at five 
minutes following delivery and for 30 babies 
(73.2%) the heart rate was persistently less 
than 100 beats per minute. Only one case was 
offered active resuscitation in the delivery 
room and none were admitted to the neonatal 
unit.
An autopsy was performed in six cases 
(14.6%) and an autopsy was offered in 24 
of the other 35 cases. Placental histology 
examination was conducted following all 41 
deaths.
7. Early neonatal deaths with a birthweight <500g and 
a gestational age at delivery <24 weeks
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Ms Bridget Boyd, Assistant Director of Midwifery, Coombe Women & Infants University Hospital
Nominated by Elizabeth Adams, Deputy Nursing Services Director, HSE
Dr Gerry Burke, Consultant Obstetrician/Gynaecologist, Midwestern Region Maternity Hospital
Nominated by the Institute of Obstetricians & Gynaecologists, RCPI
Dr David Corcoran, Consultant Neonatologist, Rotunda Hospital
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Appendix A: Perinatal Mortality Group members
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Appendix B: Endorsment of Perinatal Mortality 2013
 
National Office of Clinical Audit, 4th Floor, 121 St. Stephen’s Green, Dublin 2   Tel: 4028577                          
 
Professor Richard A. Greene 
Director 
National Perinatal Epidemiology Centre 
5th Floor, Cork University Maternity Hospital 
Wilton 
Cork 
          01st October 2015 
 
Perinatal Mortality in Ireland, Annual Report 2013 
 
Dear Professor Greene, 
 
I acknowledge receipt of NPEC’s Perinatal Mortality in Ireland, Annual Report 2013 and confirm 
following circulation to the NOCA Governance Board and feedback garnered from our membership, 
we are delighted to endorse this report.  
 
You and colleagues Ms Edel Manning, Dr Paul Corcoran, Ms Sarah Meaney and Ms Linda Drummond 
are to be congratulated for the quality of the report and manner in which you continue to engage 
with maternity services to maintain this work.   
 
We welcome your recommendations, in particular the proposal that a Confidential Enquiry for 
Stillbirth and Neonatal deaths be established in order to enhance the learning and improve care. As 
you are aware our governance requires retrospective in-depth review of audit findings outside the 
norm, your recommendation to establish a confidential enquiry certainly would align to this very 
well. 
 
Equally we fully support NPEC’s recommendation to establish a formal national perinatal pathology 
service, in association with the Faculty of Pathology which in turn will allow greater research and 
learning to the benefit of mothers and babies in Ireland. 
 
As you are aware the NOCA Board is working to convene a specialist paediatric governance group 
which we hope may go some way to support NPEC’s efforts to bring about a structured notification 
system to improve inter hospital communication when neonatal or infant deaths occur in a tertiary 
or paediatric centres.  
 
On behalf of all our associate NOCA Audit streams, we continue to highlight requirement for 
protected time of clinical staff to collect, monitor and adequately interpret audit data at hospital 
level.  
 
Finally, we welcome your efforts to accelerate the reporting process and look forward to receiving 




Professor Sean Tierney  
Chairman 
National Office of Clinical Audit 
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Appendix C: National Office of Clinical Audit 
Governance Board endorsement of Perinatal Mortality  
in Ireland Annual Report 2013 
Hospital Co-ordinators Additional contributors
Cavan General Hospital Dr Rukhsana Majeed, Dr Salah Aziz, Ms Margaret
 Ms Evelyn McAdam Mulvany, Ms Karen Malocca
Coombe Women Dr Gillian Ryan, Dr Gbenga Oluyede Dr Sharon Sheehan
and Infants University Hospital
Cork University Maternity  Dr Keelin O’Donoghue, Ms Siobhan Bourke, 
Hospital Dr Brendan Murphy 
Kerry General Hospital,  Ms Claire Fleming Kelliher, 
Tralee Ms Mary Stack Courtney 
Letterkenny General  Ms Raphael Dalton, Ms Mary Doherty, Ms Evelyn Smith
Hospital Ms Geraldine Hanley, Ms Mary Lynch 
Mayo General Hospital,  Ms Pauline Corcoran,  Dr Hilary Ikele,
Castlebar Ms Diane Brady Dr Meabh Ní Bhuinneain
Midland Regional Hospital, Mullingar Ms Marie Corbett 
Midland Regional Hospital,  Ms Emma Mullins, Ms Ita Kinsella,
Portlaoise 
Mid-Western Regional  Ms Sandra O’Connor, 
Maternity Hospital, Limerick Ms Margo Dunworth 
Mount Carmel Hospital, Dublin Ms Catherine Halloran Dr Valerie Donnelly
 Ms Felicity Doddy  
National Maternity Hospital,  Ms Fionnuala Byrne Dr Eoghan Mooney, 
Dublin   Dr Anne Twomey
Our Lady of Lourdes Hospital,  Ms Anne Keating Dr Seosamh Ó Cóigligh
Drogheda  
Portiuncula Hospital,  Ms Mairead Hynes,
Ballinasloe Ms Karen Leonard, Ms Priscilla Neilan 
Rotunda Hospital, Dublin Ms Ruth Ritchie Dr Sam Coulter Smith
Sligo Regional Hospital Ms Juliana Henry, Ms Oonagh Mc Dermott Dr Heather Langan
South Tipperary General Hospital,  Ms Siobhan Kavanagh
Clonmel  
St Luke’s Hospital, Kilkenny Ms Connie McDonagh 
University Hospital Galway Ms Marie Hession 
Waterford Regional Hospital Ms Margaret Coe, Ms Emer Denn Ms Paula Curtain
Wexford General Hospital Ms Helen McLoughlin 
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PERINATAL DEATH NOTIFICATION FORM 
2013  
 
CHOOSE Type of Case (TICK) 
  STILLBIRTH: A baby delivered without signs of life from 24 weeks’ gestation and/or with a birth weight of ≥ 
500g. 
 
 *If the birth occurred unattended and there was no lung aeration seen at Post Mortem (PM) and no other 




 EARLY NEONATAL DEATH: Death of a live born baby occurring before 7 completed days after birth. 
 
OR 
 LATE NEONATAL DEATH:  Death of a live born baby occurring from the 7th day and before 28 completed 
days after birth. 
 
 
* For the purpose of reporting, a ‘live born’ baby is defined as any baby born with evidence of life such as  
breathing movements, presence of a heart beat, pulsation of the cord or definite movement of voluntary 
muscles.   
 









The National Perinatal Epidemiology Centre is sincerely grateful for your contribution to this 
audit. 
 
Guidance for completing this form, with specific reference to Sections 11, 12 and 13 on Cause 
of Death, is outlined in the accompanying reference manual. 
 
The National Perinatal Epidemiology Centre also acknowledges with thanks the Centre for Maternal and Child 
Enquiry (CMACE) UK for permission to modify and use its Perinatal Mortality Notification Proforma for use in the 
Irish context.  
 
For NPEC Office use only:  
CODE FOR CASE  
 
PLACE OF DEATH: 
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2 
SECTION 1.  WOMANS’ DETAILS  
       1.1. Mother’s age   
1.2. Ethnic group: 
     White - Irish                               Irish Traveller  
            Any other White background         Please specify country of origin ______________________________________  
      Asian or Asian Irish                    Black or Black Irish    
     Other including mixed ethnic backgrounds: Please specify  ______________________________________________      
            Not recorded 
         
        1.3. What was the woman’s occupation at booking? 
 
 ___________________________________________________________________________________________________   
 
1.4. What was the occupation of the woman’s partner at booking?                     
 
                ___________________________________________________________________________________________________  
 
 1.5. Level of education completed by this woman: 
        Primary or less      Secondary                Third Level               Unknown   
 1.6. Height at booking (round up to the nearest cm):  
 1.7. Weight at booking (round up to the nearest kg):    
 If weight is unavailable, was there evidence that the woman was too heavy for hospital scales?  Yes  No 
 1.8. Body Mass Index at booking (BMI):  . 
 
 1.9.a. Did the woman smoke at booking?      Yes, specify quantity smoked per day__________________ 
                               No                     Unknown 
 1.9.b. Did she give up smoking during pregnancy?             Yes             No          Unknown     N/A 
 
 1.10. Is there documented history of alcohol abuse?  
        None recorded                  Prior to this pregnancy                  During this pregnancy  
 
           
       1.11. Is there documented history of drug abuse or attendance at a drug rehabilitation unit?  
              None recorded                  Prior to this pregnancy                  During this pregnancy  
SECTION 2.  PREVIOUS PREGNANCIES  
2.1. Did the woman have any previous pregnancies?    If yes, please complete questions 2.2-2.4                 Yes        No 
2.2. No. of completed pregnancies ≥24 weeks and or with a birth weight ≥ 500g (all live and stillbirths):   
2.3. No. of pregnancies <24 weeks and with a birth weight < 500g:         
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2.4. Were there any previous pregnancy problems? If yes, please tick all that apply below  Yes  No 
       Three or more miscarriages  Pre-term birth or mid trimester loss         Stillbirth, please specify number   
       Infant requiring intensive care    Baby with congenital anomaly              Neonatal death, please specify number   
Previous caesarean section Placenta praevia               Placental abruption      
Pre-eclampsia (hypertension &  proteinuria)          Post-partum haemorrhage requiring transfusion 
Other, please specify_______________________________________   Unknown 
 
 
SECTION 3.  PREVIOUS MEDICAL HISTORY 
3.1. Were there any pre-existing medical problems? If yes, please  tick all that apply below    Yes  No Unknown 
Cardiac disease (congenital or acquired)  Epilepsy  
Endocrine disorders e.g. hypo or hyperthyroidism  Renal disease 
Haematological disorders e.g. sickle cell disease       Psychiatric disorders 
Inflammatory disorders e.g. inflammatory bowel disease  Hypertension  
Diabetes  Other, please specify  ________________________  
 
 
SECTION 4.  THIS PREGNANCY 
4.1. Final Estimated Date of Delivery (EDD):      //      Unknown 
  Use best estimate (ultrasound scan or date of last menstrual period) based on a 40 week gestation, or the final date agreed 
in the notes. 
4.2. Was this a multiple pregnancy at the onset of pregnancy?             Yes       No 
 
4.3. Was this pregnancy a result of infertility treatment?                          Yes     No             Unknown 
 
               If yes, please specify method of fertility treatment _______________________________________________________________ 
  
       4.4 Gestation at first booking appointment:        weeks + days               Not booked         Unknown  
 
 4.5 Intended place of delivery at booking:  Name of unit _________________________________ 
 
Please specify the type of unit  
  Obstetric Unit      Alongside Midwifery Unit               Home                   Unbooked 
 
 4.6 What was the intended type of delivery care at booking?  
         Obstetric-Led Care         Midwifery-Led Care            Self-Employed Community Midwife      
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SECTION 5.  DELIVERY 
      
       5.1. Onset of labour: 
 Spontaneous          Induced  Never in labour  
 
5.2. Intended place of delivery at onset of labour:  Name of unit ____________________________ 
  
Please specify the type of unit 
 Obstetric Unit    Alongside Midwifery Unit     Home 
       
       5.3. What was the intended type of care at onset of labour?  
 Obstetric-Led Care         Midwifery-Led Care            Self-Employed Community Midwife      
 Home c/o Hospital DOMINO Scheme 
 
5.4. Was the intended mode of delivery a planned caesarean section?    Yes    No  
 
5.5. Place of delivery: Name of unit ____________________________________  
 
Please specify the type of unit 
  Obstetric Unit             Alongside Midwifery Unit                         Home 
 
5.6. What was the type of care at delivery?  
 Obstetric-Led Care        Midwifery -Led Care              Born Before Arrival (BBA) - Unattended      
 Self-Employed Community Midwife       Home c/o Hospital DOMINO Scheme                             
       5.7. Date and time of delivery/birth:  Date: //       Time:: 
 
5.8. What was the presentation at full dilation?  
Vertex  Breech  Compound (includes transverse and shoulder presentations)  Brow  Face    
5.9. What was the presentation at delivery?  
Vertex  Breech  Compound (includes transverse and shoulder presentations) Brow  Face    
 
5.10. What was the mode of delivery? (Please tick all that apply) 
Spontaneous Vaginal     Ventouse           Lift-Out Forceps        Mid-Cavity Forceps        Rotational Forceps         




CAESAREAN SECTIONS ONLY 
 
5.11. What was the type of or indication for Caesarean Section? 
Elective - At a time to suit woman or maternity team Urgent - Maternal or fetal compromise which is not immediately life threatening    









SECTION 6.  ALL BABY OUTCOME 
      6.1. Sex of fetus/baby:     Male    Female     Indeterminate  
      6.2. Number of fetuses/babies in this delivery: (all identifiable including papyraceous)                   
             Birth order of this fetus/baby:   
Singleton  
 Twin 1  Twin 2   
 Triplet 1  Triplet 2                 Triplet 3  
Other multiple birth pregnancy, please specify__________         Birth Order   
       
        6.3. If from a multiple delivery, what was the chorionicity? Please tick all that apply 
Dichorionic diamniotic  Monochorionic diamniotic   Monochorionic monoamniotic Trichorionic   Not known 
       
        6.4. Birth weight (kg):  .  
 6.5. Gestation at delivery:  weeks + days                        Unknown 
       6.6. Was this a termination of pregnancy?   Yes  No 
              Please refer to the reference manual, page 2   
 




SECTION 7. MATERNAL OUTCOME 
       7.1. Admission to HDU:                                                                                                                           Yes    No  
       7.2. Admission to ICU:                                                                                                                             Yes    No  
       7.3. Maternal Death:                                                                                                                                 Yes    No 
 
 
   
SECTION 8. STILLBIRTH (If not a stillbirth, please go to Section 9) 
      8.1. At what gestation was death confirmed to have occurred?  weeks + days  
      If known, what date was death confirmed?  // 
 
      8.2. Was the baby alive at onset of care in labour?   
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SECTION 9. NEONATAL DEATH ONLY 
       9.1. Was spontaneous respiratory activity absent or ineffective at 5 minutes?    Yes  No 
If a baby is receiving any artificial ventilation at 5 minutes, the assumption is absent/ineffective activity: a 0 Apgar score indicates 
absent activity.  
 
 
       9.2. Was the heart rate persistently <100bpm? ( i.e. heart rate never rose above 100bpm before death)  
                                                  Persistently <100bpm Rose above 100bpm 
      
       9.3. Was the baby offered *active resuscitation in the delivery room?                                             Yes  No 
        (*active resuscitation includes BMV, PPV, intubation, cardiac massage) 
 
 
        9.4. Was the baby admitted to a neonatal unit? (Includes SCBU and ICU)                                          Yes  No 
        9.5. Was the baby transferred to another unit after birth?                                                                   Yes  No 
   
        9.6. Date and Time of Death:                                                Date //       Time : 
 
        9.7. Place of Death*:            Labour Ward               Neonatal Unit                 Ward          
                                                In Transit                     Paediatric Centre           Home     
 
                                                           Name of unit:_____________________________________________ 
 
*This question refers to where the baby actually died, e.g. ‘ICU, ‘at home’ or ‘in transit’. 
 Babies are deemed to have died ‘at home’ if there are no signs of life documented in the home even if resuscitation is attempted. 
 A baby is deemed to have died ‘in transit’ if signs of life are documented prior to transfer but the baby was either declared dead on arrival to  
the hospital or showed no subsequent signs of life in the hospital, despite attempted resuscitation.. 
  
SECTION 10. POST-MORTEM  
       10.1. Was this a coroner’s case? If yes, please complete question 10.2.                                                   Yes   No  
10.2. Has the post-mortem report been received from the coroner’s office?                                   Yes   No 
         If no, please complete question 10.3.                                      
                                                                                                               
       10.3. Please specify which coroner’s jurisdiction this case was assigned to: _____________________________ 
                                            
 
 
10.4. Was a post-mortem performed?                                                                                   Yes  No 
         If no, please complete question 10.5. 
10.5. Was a  post-mortem offered?                                                                                        Yes  No 
 
10.6. Were any of the following procedures carried out after death?  
               Please tick all that apply    
         MRI                      X-Ray                  CT                    External Examination           
  
 






SECTION 11. CAUSE OF DEATH AND ASSOCIATED FACTORS - STILLBIRTH & NEONATAL DEATH  
 
  11. Please TICK ALL the maternal or fetal conditions that were present during pregnancy or were  
associated with the death.  PLEASE REFER TO THE REFERENCE  MANUAL. 
 
        11.1.1. MAJOR CONGENITAL ANOMALY:   
 
Central nervous system         Cardiovascular system      Respiratory system  Gastro-intestinal system    
Musculo-skeletal anomalies   Multiple anomalies          Urinary tract        Metabolic diseases      
 
 Other major congenital anomaly, please specify ________________________________________________________________ 
 
 Chromosomal disorder*, please specify ________________________________________________________________ 
      
* In the event of a chromosomal disorder how was the diagnosis made? 
 
   Clinically                               Cytogenetic analysis *                  Ultrasound                 
                                                      *See reference manual, page 2 
 
        11.1.2. HYPERTENSIVE DISORDERS OF PREGNANCY: 
 
Pregnancy induced hypertension    Pre-eclampsia  HELLP syndrome     Eclampsia  
 
        11.1.3. ANTEPARTUM or INTRAPARTUM HAEMORRHAGE:    
 
Praevia   Abruption   Cause uncertain 
 
        11.1.4. MECHANICAL:    
 
Cord compression:  Prolapse cord  Cord around neck    Other cord entanglement or knot 
Uterine rupture: Before labour During labour 
Mal-presentation: Breech                     Face  Compound  
 Transverse Other, please specify  ___________________________________  
        Shoulder dystocia:  
 
        11.1.5. MATERNAL DISORDER:       
    Pre-existing hypertensive disease   Diabetes     Other endocrine conditions (excluding diabetes)        
    Thrombophilias   Obstetric cholestasis  Uterine anomalies                       
    Connective tissue disorders, please specify______________________________________________________________________________ 
    Other, please specify_______________________________________________________________________________________________ 
 
        11.1.6. INFECTION: (confirmed by microbiology/placental histology)   
 
Maternal infection:  Bacterial    Syphilis    Viral diseases    
 Protozoal                                        Group B Streptococcus 
                                Other, please specify organism  _______________________________________________________ 
Ascending infection: 
                                                         Chorioamnionitis    Other, please specify  _________________________________ 
 
        11.1.7. SPECIFIC FETAL CONDITIONS:    
Twin-twin transfusion       Feto-maternal haemorrhage    Non-immune hydrops    Iso-immunisation    
Other, please specify _________________________________________________________________________________________________  
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        11.1.8. SPECIFIC PLACENTAL CONDITIONS:   
 
No abnormal histology reported 
Vasa praevia      Velamentous insertion                             Massive perivillous fibrin deposition   
Placental infarction           →           Please specify approximate percentage involved _______________ 
       Chorioamnionitis              →           Mild                             Moderate                          Severe 
       Fetal vasculitis             →          Arterial                    Venous                        Both      
Retroplacental haemorrhage    →    Please specify approximate percentage of maternal surface involved _______________ 
Thrombosis in fetal circulation   →   Please specify if arterial or venous _______________ 
       Villitis                     →                      Mild                             Moderate                         Severe 
Other, please specify_______________________________________________________________________________________________ 
 
        11.1.9. INTRA-UTERINE GROWTH RESTRICTION DIAGNOSIS MADE:     YES   
         
          What was this based on? Please tick all that apply 
 Suspected antenatally                    Observed at delivery                         Observed at post-mortem      
        11.1.10. ASSOCIATED OBSTETRIC FACTORS: Please tick all that apply   
        Birth trauma             Intracranial haemorrhage                         Subgaleal haematoma    
                                  Fracture, please specify_____________________________________________________ 
                                  Other, please specify________________________________________________________________________________ 
 Intrapartum fetal blood sample result < 7.25       Yes     No 
 
      Polyhydramnios                  Oligohydramnios            Premature rupture of membranes     
      Prolonged rupture of membranes (> 24hours)                Amniocentesis                             
   Spontaneous premature labour                 Other, please specify_____________________________________________________   
 











        11.1.12. UNCLASSIFIED: Please use this category as sparingly as possible   
 
SECTION 12.  MAIN CAUSE OF DEATH: STILL BIRTH & NEONATAL DEATHS 
 
     12.1. Which condition, indicated in Section 11 as being present, was the MAIN condition or sentinel event          
causing or associated with the death.  Please refer to the post-mortem report.  In the absence of a post-mortem  
report, please refer to the death certificate.  
        (NB “non-MAIN” conditions are best described as the “Other clinically relevant maternal or fetal conditions/ factors that were associated 









   12.2. Was the cause of death question completed using a placental histology report or a post-mortem report?  
               Please tick all that apply  
                 Post Mortem             Placental Histology              Both              Neither 




SECTION 13. NEONATAL DEATH ONLY:  NEONATAL CONDITIONS ASSOCIATED WITH THE DEATH 
 
 
       13.1. Please TICK ALL the neonatal conditions causing and associated with the death.  
                PLEASE REFER TO THE REFERENCE  MANUAL. 
 
        13.1.1. MAJOR CONGENITAL ANOMALY:   
 
Central nervous system         Cardiovascular system      Respiratory system  Gastro-intestinal system    
Musculo-skeletal anomalies   Multiple anomalies          Urinary tract        Metabolic diseases                              
  
Other major malformation, please specify ________________________________________________________________ 
 
 
Chromosomal disorder*, please specify ________________________________________________________________ 
      
* In the event of a chromosomal disorder how was the diagnosis made? 
 
   Clinically                                     Cytogenetic analysis *                  Ultrasound                 
                                                              *See reference manual 
 
        13.1.2. PRE-VIABLE: (less than 22 weeks)           
 
        13.1.3. RESPIRATORY DISORDERS:    
 
   Severe pulmonary immaturity    Surfactant deficiency lung disease Pulmonary hypoplasia Meconium aspiration syndrome    
 
   Primary persistent pulm. hypertension          Chronic lung disease / Bronchopulmonary dysplasia (BPD)   




        13.1.4. GASTRO-INTESTINAL DISEASE:    
 
Necrotising enterocolitis (NEC)    Other, please specify __________________________________________________________________ 
 
 
        13.1.5. NEUROLOGICAL DISORDER:   
 
Hypoxic-ischaemic encephalopathy (HIE)                                                  
 
*Intraventricular / Periventricular haemorrhage, please specify highest grade (0 – 4) *           
    Hydrocephalus*,  please tick all that apply: 
                   * Congenital              Acquired                     Communicating                   Obstructive       Other__________________            
 
 
Other, please specify______________________________________________________________________________________________ 
 
 
        13.1.6. INFECTION:   
 
Generalised (sepsis)     Pneumonia      Meningitis       
Other, specify ______________ 
 
 
        13.1.7. INJURY / TRAUMA: (Postnatal)     
  
 
             Please specify_______________________________________________________________________________________________________ 
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        13.1.8. OTHER SPECIFIC CAUSES:   
 
Malignancies / Tumours              In-born errors of metabolism, please specify ___________________________________ 
Specific conditions, please specify___________________________________________________________________________ 
 
 
        13.1.9. SUDDEN UNEXPECTED DEATHS:   
 
Sudden Infant Death Syndrome (SIDS)        Infant death – Cause unascertained 
 
        13.1.10. UNCLASSIFIED: (Use this category as sparingly as possible)   
 
 
      13.2. Which condition, indicated in Section 13.1 as being present, was the MAIN condition causing or 
associated with the death.  Please refer to the post-mortem report.  In the absence of a post-mortem report, please 
refer to the death certificate.  
        (NB “non-MAIN” conditions are best described as the “Other clinically relevant maternal or fetal conditions/ factors that were associated 









     
      13.3. Was the cause of death question completed using a placental histology or a post-mortem report?  
                Please tick all that apply  
              
 





SECTION 14. DETAILS OF REPORTING UNIT (Please print) 
        
   14.1. Name of reporting unit: ______________________________________________________________________ 
       14.2. Completed by 
          Name: _________________________________________________________________________________________ 
          Staff Grade: ____________________________________________________________________________________ 
          Work address: __________________________________________________________________________________ 
          _______________________________________________________________________________________________ 
          Telephone Number: _____________________ 
          E-mail Address:_________________________ 












Guidance and Definitions for Completion of Section 11 & 12 
STILLBIRTH AND NEONATAL DEATH 
 
DEFINITION OF TERMS Subcategory 
1. MAJOR CONGENITAL ANOMALY. Any genetic or structural defect arising at conception or 
during embryogenesis incompatible with life or potentially treatable but causing death 
 
Central nervous system    
Cardiovascular system 
Respiratory system  
Gastro-intestinal system  
Musculo-skeletal anomalies 
Multiple anomalies   
Chromosomal disorders 
Metabolic diseases  
Urinary tract 
Other 
2. HYPERTENSIVE DISORDERS OF PREGNANCY. 
 




3. ANTEPARTUM OR INTRAPARTUM HAEMORRHAGE. After 20 w gestation, whether 
revealed or not. If associated with PET, APH will be a secondary diagnosis. Ignore minor degrees 
of haemorrhage (e.g. ‘shows’, cervical polyps etc). Recurrent bleeding of uncertain origin followed 





4. MECHANICAL. Any death attributed to uterine rupture, deaths from birth trauma or intrapartum 
asphyxia associated with problems in labour such as cord compression, malpresentation, 
shoulder dystocia etc. 
Antepartum deaths associated with cord entanglement in the absence of strong circumstantial          
evidence that cord compression caused death should be classified as having no associated 
factor. 
 
Cord Compression  
Prolapse cord  
Cord around neck 
Other cord entanglement or knot 




Breech / Transverse   
       Face / Compound 
Other  
Shoulder dystocia 
5. MATERNAL DISORDER. Specify hypertensive disease present before pregnancy or any 
other maternal disease or condition sufficient to jeopardise the baby such as diabetes, cardiac 
disease etc.  
Infection is classified separately. 
 
Pre-existing hypertensive disease  
Diabetes  
Other endocrine conditions 
Thrombophilias   
Obstetric cholestasis   
Drug misuse    
Uterine anomalies 
Connective tissue disorders / Other  
6. INFECTION. Confirmed by microbiology / placental histology. 
Specify maternal infections sufficient to have compromised the baby which may be associated 
with      congenital infection of the baby. Trans-placental transmission may have occurred such as 
CMV, toxoplasmosis etc.  
Specify only those ascending infections that are a significant factor in death. Chorioamnionitis 
sufficient to cause preterm birth may be specified for some neonates but evidence of fetal 
infection may be required as an explanation of stillbirth.  
Maternal infection 
Bacterial / Viral diseases  
Syphilis  /Group B Streptoccus  
Protozoal 
Other 
Ascending infection  
Chorioamnionitis 
Other 









8. SPECIFIC PLACENTAL CONDITIONS. Specific placental conditions sufficient to cause 
death or be associated with fetal compromise such as IUGR. These will often be secondary to 
other maternal conditions e.g. PET. 
Cord problems associated with compression will normally be classified under ‘Mechanical’ 
Placental infarction   
Retroplacental haemorrhage         




Massive perivillous fibrin deposition 
Vasa praevia / Velementous insertion 
Other 
9. INTRA-UTERINE GROWTH RESTRICTION DIAGNOSIS MADE. IUGR may be 
suspected antenatally by abdominal circumference (AC) less than the centile threshold used to 
define IUGR locally, or decreased AC growth velocity, +/- oligohydramnios. 
Suspected antenatally 
Observed at delivery 
Observed at post mortem 
10. ASSOCIATED OBSTETRIC FACTORS. Factors recorded as Other Associated Obstetric 
Factors will be important clinical or pathological features of the pregnancy or baby but will not be 
an explanation of the death; they will often be secondary to other maternal or fetal conditions. 
Birth trauma and/or Intrapartum asphyxia should normally be classified primarily by the underlying 
cause (e.g Mechanical ). Birth Trauma and/or other antenatal/intra-partum factors can be 





Birth injury to scalp 
Fracture 
Other 





Premature rupture of membranes 




11. NO ANTECEDENT OR ASSOCIATED OBSTETRIC FACTORS. Deaths with no 
explanation or significant associated factor. 
 
12. UNCLASSIFIED.  Cases where little or nothing is known about pregnancy or delivery and 










Guidance and Definitions for Completion of Section 13: 
NEONATAL DEATH ONLY 
 
The following definitions and associated subcategories will help you choose the relevant 
neonatal conditions causing and associated with death 
 
DEFINITION OF TERMS Subcategory 
MAJOR CONGENITAL ANOMALY. Any genetic or structural defect arising at conception or 
during embryogenesis incompatible with life or potentially treatable but causing death. 







Metabolic disorders  
Urinary tract  
Other 
PRE-VIABLE. Babies (less than 22 weeks) who are non-viable at birth because of gestation but 
who show signs of life. 
 
RESPIRATORY DISORDERS. Severe pulmonary immaturity will encompass those babies 
where structural lung immaturity is so gross as to mean ventilatory support is unsustainable at the 
outset, usually babies between 22 – 24w gestation. Surfactant Deficient Lung Disease may 
include babies with clinical or pathological evidence of hyaline membrane disease.  
Severe pulmonary immaturity 
Surfactant deficiency lung disease 
Pulmonary hypoplasia 
Meconium aspiration syndrome 
Primary persistent pulmonary hypertension 
Chronic lung disease / BPD 
Other (includes pulmonary haemorrhage) 
GASTRO-INTESTINAL DISEASE. Many babies with NEC will have associated sepsis which 
may be given as a secondary cause.  
Necrotising enterocolitis (NEC) 
Other 
NEUROLOGICAL DISORDER. HIE includes those babies with severe hypoxic-ischaemic 
brain injury before birth. If possible, please specify if HIE was primarily of intrapartum or 
antepartum origin. Specify periventricular leukomalacia only if this is a significant factor in the 
infant death. Birth Trauma will usually be classified here.  




INFECTION. Where possible specify the location of infection and whether due to bacteria, virus, 
fungus or other specific organism.   
If infection was the main cause of death please specify whether infection is congenital (i.e. 






INJURY / TRAUMA. Post natal trauma only including iatrogenic injury. ‘Birth Trauma’ will 
usually be classified under neurological disorder e.g. HIE; the obstetric classification identifying 
the timing of the injury.  
 
OTHER SPECIFIC CAUSES. Death due to specific fetal and neonatal conditions such as 
isoimmunisation or unexplained hydrops. Neonatal conditions will include aspiration, unexplained 
pulmonary haemorrhage.  
Malignancies/Tumours 
Specific conditions 
SUDDEN UNEXPECTED DEATHS. SIDS should conform to the accepted definition. 
Unascertained are those unexpected deaths that are not explained despite a full investigation 
including autopsy, but do not conform to the accepted definition of SIDS. 
Sudden Infant Death Syndrome (SIDS) 
Infant deaths – cause unascertained 
UNCLASSIFIED.  Cases where little or nothing is known about the pregnancy or delivery and 









11. NO ANTECEDENT OR ASSOCIATED OBSTETRIC FACTORS. Deaths with no 
explanation or significant associated factor. 
 
12. UNCLASSIFIED.  Cases where little or nothing is known about pregnancy or delivery and 










Guidance and Definitions for Completion of Section 13: 
NEONATAL DEATH ONLY 
 
The following definitions and associated subcategories will help you choose the relevant 
neonatal conditions causing and associated with death 
 
DEFINITION OF TERMS Subcategory 
MAJOR CONGENITAL ANOMALY. Any genetic or structural defect arising at conception or 
during embryogenesis incompatible with life or potentially treatable but causing death. 







Metabolic disorders  
Urinary tract  
Other 
PRE-VIABLE. Babies (less than 22 weeks) who are non-viable at birth because of gestation but 
who show signs of life. 
 
RESPIRATORY DISORDERS. Severe pulmonary immaturity will encompass those babies 
where structural lung immaturity is so gross as to mean ventilatory support is unsustainable at the 
outset, usually babies between 22 – 24w gestation. Surfactant Deficient Lung Disease may 
include babies with clinical or pathological evidence of hyaline membrane disease.  
Severe pulmonary immaturity 
Surfactant deficiency lung disease 
Pulmonary hypoplasia 
Meconium aspiration syndrome 
Primary persistent pulmonary hypertension 
Chronic lung disease / BPD 
Other (includes pulmonary haemorrhage) 
GASTRO-INTESTINAL DISEASE. Many babies with NEC will have associated sepsis which 
may be given as a secondary cause.  
Necrotising enterocolitis (NEC) 
Other 
NEUROLOGICAL DISORDER. HIE includes those babies with severe hypoxic-ischaemic 
brain injury before birth. If possible, please specify if HIE was primarily of intrapartum or 
antepartum origin. Specify periventricular leukomalacia only if this is a significant factor in the 
infant death. Birth Trauma will usually be classified here.  




INFECTION. Where possible specify the location of infection and whether due to bacteria, virus, 
fungus or other specific organism.   
If infection was the main cause of death please specify whether infection is congenital (i.e. 






INJURY / TRAUMA. Post natal trauma only including iatrogenic injury. ‘Birth Trauma’ will 
usually be classified under neurological disorder e.g. HIE; the obstetric classification identifying 
the timing of the injury.  
 
OTHER SPECIFIC CAUSES. Death due to specific fetal and neonatal conditions such as 
isoimmunisation or unexplained hydrops. Neonatal conditions will include aspiration, unexplained 
pulmonary haemorrhage.  
Malignancies/Tumours 
Specific conditions 
SUDDEN UNEXPECTED DEATHS. SIDS should conform to the accepted definition. 
Unascertained are those unexpected deaths that are not explained despite a full investigation 
including autopsy, but do not conform to the accepted definition of SIDS. 
Sudden Infant Death Syndrome (SIDS) 
Infant deaths – cause unascertained 
UNCLASSIFIED.  Cases where little or nothing is known about the pregnancy or delivery and 
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